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Abstract
18F-fallypride is of interest in neurological and psychiatric diseases to visualise 
dopamine D2/D3 receptors in striatal and extrastriatal regions.  
Several simplified methods of quantifying positron emission tomography (PET) brain 
imaging using 18F-fallypride have been described and used on real data using non-
invasive methods, but a systematic analysis of their effect on quantification has not 
been performed. 
In this study, mathematical simulations were used to study this effect on 
quantification using different models to quantify 18F-fallypride PET in the human 
brain. The specific uptake areas of interest used in this study for a human brain are 
the putamen (high receptor density region), thalamus (moderate receptor density 
region) and temporal cortex (low receptor density region). 
Materials and methods 
 All simulations were performed using Matlab (version R2013a (8.1.0.604) win 64-bit 
software; MathWorks, Inc.). 
Simulations of realistic measurements were performed by modelling varying frame 
duration, decay of the tracer, and varying noise levels, starting from ideal tissue 
curves. A modelled input function was used for the generation of ideal tissue curves. 
Quantification was carried out with arterial blood sampling models: a 2T4k (two-
tissue (or three-compartment) reversible model was used and a Logan graphical 
analysis was applied. 
Using the cerebellum as the reference region, we studied the following reference 
region models: Logan graphical analysis (Loganref) using a reference region, the 
reference tissue model (RTM) and the simplified reference tissue model (SRTM). 
Finally, the standard uptake value ratio (SUVR) was studied as the simplest method. 
For the assessment, the results were analysed using a correlation analysis and a 
Bland-Altman analysis and the relative error (%) and the 5th and 95th percentiles in 
high/moderate/low receptor density region of the brain were determined. Validation of 
each method was done in terms of bias and variance. 
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Results 
The study showed that in all cases the ground truth method and the graphical 
method using an arterial input function were nearly identical.  
The overall accuracy and variability of various methods were determined 
successfully. Loganref was the most accurate, with the highest precision as the 
replacement of the invasive arterial blood sampling in low/moderate receptor density 
regions. While SRTM gave high precision in high receptor density region, SUVR 
calculations produced relatively large errors in all receptor density regions used in 
this study. 
The effect of SNR (signal to noise ratio) on quantification was clearly observed since 
the bias in all reference region methods increased with increasing noise. When the 
noise level is too high, bias may become too large.  
Investigating the effect of the models’ performance under a continuous sampling 
scheme showed the stability in the kinetics of 18F-fallypride using non-invasive 
reference region methods when the scan length (continuous sampling scheme) was 
> 150 min and > 120 min in high and in low/moderate receptor density regions 
respectively. 
To achieve a good compromise between accuracy and patient comfort, breaks can 
be introduced at pre-determined intervals. Best results were achieved when the total 
scan time was 90 min and the total break time was 150 min (i.e. 30 min scan + 30 
min break + 30 min scan + 120 min break + 30 min scan). 
Conclusion 
Simplified models can be used to provide useful estimates of dopamine transporters 
that are comparable to methods using arterial blood sampling. However, these 
models should be used with great care as they can be affected by the noise in the 
data, the length of the scan duration and the length and position of the breaks in the 
imaging sequence.  
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Opsomming 
18F-Fallypride is van waarde in neurologiese en psigiatriese siekte om dopamien 
D2/D3 reseptore in striatale en ekstrastriatale areas te visualiseer.  
Verskeie vereenvoudigde metodes vir kwantifisering van 18F-fallypride positron 
emissie tomografie (PET) breinbeelding, is deur middel van nie-ingrypende metodes 
op ware data beskryf en gebruik. Systemiese analise van die effek van hierdie 
metodes op kwantifisering is nog nie uitgevoer nie. 
In die huidige studie, is wiskundige simulasies gebruik om hierdie invloed op die 
kwantifisering te bestudeer, deur van verskillende metodes gebruik te maak om 18F-
Fallypride PET in die menslike brein te kwantifiseer. Die spesifike areas van opname 
in hierdie studie, is die putamen (hoë reseptor digtheidsarea), talamus (matige 
reseptor digtheidsarea) en temporale korteks (lae digtheidsarea).  
Materiaal en metodes 
Alle simulasies is op Matlab (weergawe R2013a (8.1.0.604) win 64-bit sagteware; 
MathWorks, Inc.) uitgevoer.  
 
Die werklike metings is gesimuleer deur modellering met wisselende raamduur, 
verval van spoorelemente en wisselende geraasvlakke, gebasseer op ideale 
weefselkurwes. ‘n Gemodelleerde insetfunksie is gebruik vir die konstruksie van 
ideale weefselkurwes. Kwantifisering is uitgevoer met arteriële bloedmonster-
modelle: ‘n 2T4k (twee-weefsel of drie-kompartement) omkeerbare model en ‘n 
Logan grafiese analise. Die serebellum is as verwysingsgebied gebruik, om die 
volgende modelle te bestudeer: ‘n Logan grafiese analise (Loganref), ‘n 
verwysingsweefsel-model (VWM) en die vereenvoudigde verwysingsweefsel-model 
(VVWM). Laastens is die standard-opname verhoudingswaarde as die eenvoudigste 
metode gebruik. 
 
Die resultate is geanaliseer deur van ‘n korrelasie-analise en ‘n Blandt-Altman 
analise gebruik te maak. Die relatiewe fout (%), sowel as die 5de en 95ste persentiel in 
hoë/middelmatige/lae reseptor digtheidsarea van die brein, is bepaal. Die geldigheid 
van elke metode is geëvalueer in terme van vooroordeel en variasie.  
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Resultate 
Die studie het in alle gevalle getoon dat die grondwaarheidsmetode en die grafiese 
metode, wat van die arteriële insetfunksie gebruik maak, byna identies is. Die 
algehele akkuraatheid en die veranderlike van die verskillende metodes, was 
suksesvol. Loganref analise was die akkuraatste in die lae/middelmatige reseptor-
digtheidsareas in plaas van die gebruik van die ingrypende arteriële bloedmonster 
metode.   
 
Die vereenvoudigde verwysingsweefsel-model (VVWM) was die akkuraatste in die 
hoë reseptor digtheidsarea, daarenteen het die standard-opname 
verhoudingswaarde relatief groot foute getoon.  
Die effek van sein tot geraasverhouding op kwatifisering was duidelik, aangesien die 
vooroordeel van alle verwysingsgebied-metodes met toenemende geraas verhoog 
het. Wanneer die geraasvlak egter te hoog is, word die vooroordeel ook te groot.  
‘n Ondersoek na die effek van modelverrigting onder die aaneenlopende 
monsterprogram, toon stabiliteit in die kinetika van 18F-fallypride.  Hierdie effek vind 
plaas met die gebruik van ‘n minder ingrypende verwysingsmetode wanneer die 
beeldingstyd > 150 minute en > 120 minute in onderskeidelik hoë en in 
lae/middelmatige reseptor- digtheidsareas is.  
Die beeldingtydsduur met tussensposes was gebruik om ‘n ooreenkoms tussen 
akkuraatheid en pasiëntgemak te bereik. Die beste kwantitatiewe resultate is verkry 
met die volgende program: 30 minute beelding, 30 minute tussenpose, gevolg deur 
30 minute beelding met ‘n 120 minute onderbreking en laastens weer ‘n 30 minute 
beelding. 
Gevolgtrekking 
Vereenvoudigde modelle kan gebruik word om nuttige voorspellings van dopamien- 
draers, te verkry, wat vergelykbaar is met metodes waar arteriële bloedmonsters 
gebruik word. Die modelle moet egter met groot sorg gebruik word, aangesien dit 
deur datageraas, die duur van die beelding, die tipe onderbrekings of die 
onderbreking van die monsterprogram, beïnvloed kan word. 
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Chapter 1: Introduction to the context of the study 
1.1   Background 
1.1.1   Functional neuroimaging 
Over the years, understanding the development of the brain has led to the cognitive 
neuroscience and the rise of functional neuroimaging (Morita et al., 2016). 
Functional neuroimaging is a research tool which uses technology to measure the 
activity of the brain function (specific mental functions) in real time and captures 
images of the different brain anatomy structures. This provides an in vivo window into 
the human brain network by finding the relationship between the brain function and 
its anatomy (Meier et al., 2016). 
Humans are prone to physical and mental changes throughout their lifespan (Morita 
et al., 2016). Functional neuroimaging of the brain plays an important role in 
neuroscience for the study of neurological and psychiatric disorders to measure 
these changes, as well as for early stage drug development. Even though the 
neurological (disorders of the brain) and psychiatric disease (disorders of the mind) 
are considered “disorders of the nervous system”, both of them express two different 
kinds of disorders from a perspective of neuroimaging (Crossley et al., 2015). 
Psychiatric disorders are different than neurological disorders, changes in the 
neuroimaging study can not be seen with the naked eye when assessing psychiatric 
disorders (Masdeu et al., 2011).  
The most commonly used functional neuroimaging techniques are electro-
encephalography (EEG) and magneto-encephalography (MEG) to measure the 
electric activity of cell groups in the brain; functional magnetic resonance imaging 
(fMRI), near-infrared spectroscopy (NIRS), single-photon emission computerised 
tomography (SPECT) and positron emission tomography (PET) to measure the 
change in blood flow associated with brain activity (Morita et al., 2016; Lystad et al., 
2009). 
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1.1.2   Positron Emission Tomography (PET) 
PET is a non-invasive medical technique used to generate high-resolution images 
and enables in vivo examination of human and animal brain functions including 
physiological functions focusing on cerebral blood flow and metabolism, including 
neurotransmitters, receptor binding and radiolabelled drugs (Tai et al., 2005). 
It involves an intravenous administration of a radioactive tracer into the human body, 
usually labelled positron emitting isotopes such as 15O (oxygen-15), 18F (fluorine-18), 
11C (carbon-11), or 13N (nitrogen-13). 
These unstable positron emitting isotopes are prepared with a particle accelerator 
(cyclotron), and they have relatively short half-lives.  They reach stability when they 
decay into a neutron, a positron, and a neutrino. The emitted positron travels only a 
few millimetres and meets an electron inside the patient’s body. When the electron 
and positron meet (annihilation), two gamma rays are produced and released at 180 
degrees with the energy of 511keV each moving in opposite directions.  
When these gamma rays are detected at the same time, high spatial resolution 
image is produced by PET.  
PET plays a role by measuring in vivo neurotransmitter and receptor activity in the 
brain in healthy and diseased states (Sossi at al., 2003; Patel et al., 2010). 
 
1.1.3   Neurotransmitters 
Neurotransmitters are endogenous chemicals which allow the transport of signals 
between neurons across synapses.  
They are clustered in synaptic vesicles. When released, they bind to the receptors of 
the synapse. 
Different types of neurotransmitters include amino acids, monoamines and other 
biogenic amines. 
Amino acids include glutamate, aspartate, D-serine, γ-aminobutyric acid (GABA), 
glycine while monoamines and other biogenic amines include dopamine (DA), 
norepinephrine, epinephrine, histamine, serotonin (5-HT). Other neurotransmitters 
are acetylcholine (ACh), adenosine, anandamide and nitric oxide. 
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1.1.4   Dopamine (DA) 
DA neurons reside in the substantia nigra and some in ventral tegmental area of the 
brain.   
DA plays a major contribution in a range of neurological and psychiatric disorders 
including Parkinson's disease, schizophrenia and drug addiction (Zald et al., 2010). 
It is a neurotransmitter in the brain that plays an important role in the control of motor 
function, reward, and emotional expression including neuroendocrine release and 
behavioural homeostasis in the central and peripheral nervous system (D’Souza et 
al., 2010). 
 
1.1.5   Dopamine D2/D3 receptors  
A receptor is a protein that resides on the membrane of the neuronal synapse. 
Neurotransmitters bind to receptors using a lock and key mechanism, where the key 
in this case is a neurotransmitter and the lock a receptor. 
Neuroreceptor imaging gives researchers an opportunity to gain access to 
quantitative information based on the distribution of the receptors in the human brain.  
The involvement of DA system has been found in different neurological and 
neuropsychiatric processes (Hurd and Hall et al., 2005; Christian et al., 2009). 
Dopamine D2/D3 receptors are an important target in understanding and treating 
neurological and psychiatric disorders. 
It has been pointed out that the highest concentration of D2 receptors is found in 
striatum, while D3 receptors can be found in low concentrations in the extrastriatal 
brain (Volkow et al., 1996). The D3 receptor is mainly linked to the limbic system 
(Cave et al., 2009). Dopamine D2/D3 receptors play a major role in cognitive and 
behavioural output and disruption (Vandehey et al., 2010). 
 
1.1.6   The properties of 18F-fallypride and its importance for quantification of D2/D3 
receptors 
To quantify striatal and extrastriatal D2/D3 receptors in PET imaging, 
18F-fallypride is 
a radiotracer of interest (Gründer et al., 2008; Vernaleken et al., 2011). It binds to DA 
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D2 and D3 receptors and gets distributed in the brain in striatal and extrastriatal 
regions but shows insignificant binding to other common neuroreceptors. 
 
The fluorine-18 label of 18F-fallypride provides the benefits of a longer physical half-
life (109.8 minutes) in comparison to the carbon-11 label of 11C-raclopride. 18F-
fallypride is thus a tracer of choice as a PET radiopharmaceutical for the study of 
both striatal and extrastriatal DA receptors in a single PET scan. An advantage of 
18F-fallypride is that it does not form metabolites in the brain. Metabolites created 
outside the brain region do not pass over the blood brain barrier. 
The quantification of neuroreceptor imaging information based on PET can be 
derived accurately taking into account the concentration of free and non-specifically 
bound tracer, and the concentration of the tracer bound to the brain receptors. 
Additional quantification includes the delivery, uptake, binding, clearance or washout 
of the radiotracer and its transport across the blood brain barrier.  
Using models for the behaviour of the tracer in vivo and with measurements of the 
tracer distribution over time using PET, relevant parameters (e.g. binding potential 
(BPND), volume of distribution (DV)) can be derived using kinetic modelling (Heiss 
and Herholz 2006). 
Quantification of brain PET imaging using 18F-fallypride has been performed using 
different kinetic modelling methods, each based on the different assumptions 
regarding the complex pathways these tracers follow in brain tissue (Cropley et al., 
2008; Matsubara et al., 2011). 
 
1.2   Reconstruction of 18F-fallypride two tissue (or three-compartment) model 
(2T4k) 
It is important to know the amount of tracer that will be trapped at metabolism site or 
the tracer bound to the brain receptors.  
The complex pathways of the tracer’s molecule in the brain can be divided into 
segments known as compartments. For example, the molecules that are bound to 
the brain receptors can constitute one compartment.  
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Fallypride bound to 
D2/D3 receptors 
CB(t) 
Free and non-
specifically bound 
Fallypride  
CF+NS(t) 
The idea is to move from a highly complex physiological system to a simplified 
compartmental model. Compartmental model is used to analyse dynamic PET data. 
The principle of the compartmental model is to eliminate invasive procedures with 
highly predictive power to provide mathematical solution. 
In simple terms, the compartmental models describe the kinetics of a tracer injected 
into a physiological system which is the brain in this case. 
In pharmacokinetic modelling, the behaviour of the tracer in tissue is assumed to be 
separated into multiple “compartments”. This means the tracer can be specifically 
bound, nonspecifically bound or move freely in tissue. The compartments in figure 
1.1 are chemical species in a physical place and they are represented by boxes while 
the connections between these compartments are represented by arrows (known as 
fallypride exchange rate constants). 
Every compartment has several exchange rate constants leading to the region of 
interest (inflows) and several exchange rate constants leading from the region of 
interest (outflows). 
 
 
 
 
 
 
 Figure 1.1: Two tissue (or three-compartment) model or (2T4k) of 
18
F-fallypride 
Figure 1.1 provides the general 2T4k model of 18F-fallypride and an overview of the 
various paths that fallypride may follow after delivery by intravenous injection. This 
model consists of components of plasma, free and non-specifically bound ligand in 
tissue and ligand bound to D2/D3 receptors in tissue.   
The tracer inside a compartment is assumed to be well mixed, kinetically 
homogeneous and distributed uniformly, meaning all the molecules of the tracer in a 
particular compartment have equal chance to exchange into other compartments. 
k3 
 
 
k4 
 
 
 
K1 
 
 
k2 
 
 
 
Fallypride  
in plasma 
CP(t) 
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This assumption simplifies the mathematics of compartmental modelling but also 
produces limitations of the compartment models to accurately describe some 
biological structures. Carson (2005, p. 132)  
First compartment is used for the input function, it represents the concentration of 
tracer in arterial blood plasma as a function of time CP(t), therefore, the concentration 
of the tracer in the plasma is referred to as input function. 
There is no need to define this compartment with an equation because the arterial 
blood plasma curve is measured. 
From arterial blood, the radioligand is transported into the second compartment, free 
and non-specifically bound compartment. In the compartment, the free tracer in 
tissue can diffuse back into the blood or bound non-specifically to other cells than the 
target. This is represented by the concentration CF+NS(t) of 
18F-fallypride in tissue.  
The main interest is in the third compartment. In this compartment, the tracer in the 
tissue has been bound to D2/D3 receptors site. The concentration in this 
compartment is represented by CB(t). 
The relationship between the different compartments is described by four rate 
constants (K1–k4). The rate constant in the compartmental model represents the 
amount of the total tracer leaving that compartment per unit time (fractional 
clearance). The unit of the rate constant is the inverse of time i.e., the fraction of 
tracer molecules required to travel in another compartment in one minute. 
 
K1 has a perfusion-dependent entity, this is indicated by capital letter (K). Perfusion is 
the volume of blood delivered through certain mass (or volume) of tissue per unit 
time. Blood flow is usually given in units (ml.g-1.min-1) or (ml.ml-1.min-1) or (ml.cm-
3.min-1). Since the units of volume cancel out, therefore K1 has the units of per minute 
(min-1). 
In this study, for the transport and binding rates of the tracer, K1, k2, k3, and k4 have 
units of per minute (min-1), indicating the fraction of mass or volume transferred per 
unit time. 
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1.2.1   Mathematical description of 2T4k model and the estimation of the model  
parameters 
The dynamics of the tracer molecule are governed using the mathematical models to 
analyse PET data. 
The concentration in each compartment is time dependent, and these concentrations 
are therefore related through sets of ordinary differential equations (ODEs) which can 
be solved simultaneously to determine the quantities of interest. 
From figure 1.1, only the second CF+NS(t) and the third compartment CB(t) can be 
defined with mathematical equations. The first compartment CP(t) is regarded as the 
input function where the arterial blood curve is measured, for this reason it not 
necessary to define it using the ordinary differential equations. 
Table 1.1 shows how ODEs were reconstructed to define the mathematical 
description of the 2T4k model in the second compartment and Table 1.2 shows these 
ODEs in the third compartment. 
In general, the rate of change of the amount of the fallypride in any compartment is 
equal to the sum of the rates of fallypride transfer into the compartment minus the 
sum of the rates of fallypride transfer out of the compartment. 
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Table 1.1 Reconstruction of ODEs for 2T4k model in the second compartment 
 
Compartments layout 
and the direction of 
exchange rate constant 
flow 
 
The rate 
of change 
 
The sign of 
flow 
 
Rate 
constant 
 
Ordinary differentials equations 
(ODEs) 
From 𝑪𝑷(𝒕) to  𝑪𝑭+𝑵𝑺(𝒕)    
 
 
 
 
 
 
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
 
 
Inflow = 
positive (+) 
 
 
𝐾1 
       
  
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
= 𝐾1𝐶𝑃(𝑡)                  (1) 
From  𝑪𝑭+𝑵𝑺(𝒕) to 𝑪𝑷(𝒕) 
  
 
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
 
 
Outflow = 
negative (-) 
 
𝑘2 
        
 
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
= −𝑘2𝐶𝐹+𝑁𝑆(𝑡)          (2) 
From 𝑪𝑭+𝑵𝑺(𝒕) to  𝑪𝑩(𝒕) 
 
 
 
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
 
 
Outflow = 
negative (-) 
 
𝑘3 
 
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
= −𝑘3𝐶𝐹+𝑁𝑆(𝑡)           (3) 
From 𝑪𝑩(𝒕) to 𝑪𝑭+𝑵𝑺(𝒕) 
    
 
 
 
 
 
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
 
 
Inflow = 
positive (+) 
 
𝑘4 
 
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
= 𝑘4𝐶𝐵(𝑡)                    (4) 
Note: The rate of transfer carries a positive (+) sign if it points into the compartment and a negative (-) 
sign if it points out of the compartment. 
The rate of change  
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
 of the amount of the fallypride moving in and out of the 
second compartment (𝐶𝐹+𝑁𝑆(𝑡)), is equivalent to the sum of equations (1) to (4), 
which is described by the following differential equation.  
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
= 𝐾1𝐶𝑃(𝑡)−𝑘2𝐶𝐹+𝑁𝑆(𝑡)−𝑘3𝐶𝐹+𝑁𝑆(𝑡) + 𝑘4𝐶𝐵(𝑡)                                              (5) 
 
K1 CP(t) CF+NS(t) 
 k2 
CP(t) CF+NS(t) 
k3 CF+NS(t) CB(t) 
 k4 
CF+NS(t) CB(t) 
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Rearranging equation (5) gives the following ODE: 
  
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
 = 𝐾1𝐶𝑃(𝑡)−(𝑘2+𝑘3)𝐶𝐹+𝑁𝑆(𝑡) + 𝑘4𝐶𝐵(𝑡)                                                   (5.1) 
Table 1.1 Reconstruction of ODEs for 2T4k model in the third compartment 
 
Compartments layout 
and the direction of 
exchange rate constant 
flow 
 
The rate 
of change 
 
The sign of 
flow 
 
Rate 
constant 
 
Ordinary differentials equations 
(ODEs) 
From 𝑪𝑭+𝑵𝑺(𝒕) to  𝑪𝑩(𝒕)  
 
 
 
𝑑𝐶𝐵(𝑡)
𝑑𝑡
 
 
Inflow = 
positive (+) 
 
 
𝑘3 
 
𝑑𝐶𝐵(𝑡)
𝑑𝑡
= 𝑘3𝐶𝐹+𝑁𝑆(𝑡)                (6) 
From 𝑪𝑩(𝒕) to 𝑪𝑭+𝑵𝑺(𝒕) 
   
 
 
𝑑𝐶𝐵(𝑡)
𝑑𝑡
 
 
Outflow = 
negative (-) 
 
𝑘4 
 
𝑑𝐶𝐵(𝑡)
𝑑𝑡
= −𝑘4𝐶𝐵(𝑡)                  (7) 
Note: The rate of transfer carries a positive (+) sign if it points into the compartment and a negative (-) 
sign if it points out of the compartment. 
Similarly rate of change 
𝑑𝐶𝐵(𝑡)
𝑑𝑡
 of the amount of the fallypride moving in and out of the 
third compartment (𝐶𝐵(𝑡)), is the sum of equations (6) and (7), which is described by 
the following differential equation.  
𝑑𝐶𝐵(𝑡)
𝑑𝑡
= 𝑘3𝐶𝐹+𝑁𝑆(𝑡) − 𝑘4𝐶𝐵(𝑡)                                                                                     (8) 
The transport and binding rates of the tracer are assumed to be linearly related to the 
concentration differences between two compartments, and thus equation (5.1) and 
equation (9) first-order differential equations describe the model of figure 1.1 at time t 
[min] (Heiss and Herholz 2006). 
 
 
 
k3 CF+NS(t) CB(t) 
 k4 
 
CF+NS(t) CB(t) 
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The compartment activities given in equation (5.1) and (8) are not individually 
accessible from imaging measurements but their sum given in equation (9) below 
can be measured. 
 
𝐶𝑇(𝑡) = 𝐶𝐹+𝑁𝑆(𝑡) + 𝐶𝐵(𝑡)                                                                                            (9) 
where, 
𝐶𝐹+𝑁𝑆(𝑡)  = Concentration of free and non-specifically bound fallypride in brain tissue           
                  in [kBq/ml]    
𝐶𝑃     = Concentration of fallypride in the arterial plasma in [kBq/ml]    
𝐶𝐵      = Concentration of fallypride bound to D2/D3 receptors in [kBq/ml]    
𝐶𝑇    = Total concentration of fallypride in tissue in [kBq/ml]    
K1 to k4    = Fallypride exchange rate constants associated with delivery, uptake, 
                binding, and clearance. 
where:       
𝐾1 [min
−1] = net influx or the delivery of the tracer to the brain 
𝑘2 [min
−1] = washout of the tracer from the brain 
𝑘3 [min
−1] = forward receptor-ligand reaction, the delivery of the tracer to D2/D3     
                  receptors in tissue 
𝑘4 [min
−1] = reverse receptor-ligand reaction, the clearance or washout of the tracer        
                   from D2/D3 receptors in tissue 
The ground truth compartmental model described in figure 1.1 can be converted into 
mathematical form giving a rise to a solution obtained by solving the ordinary 
differential equations and by estimating the rate constants given an arterial input 
function 𝐶𝑃(𝑡) and given the PET measurement 𝐶𝑇  over tissue. 
The total concentration of fallypride in tissue represented by equation (9) can be 
expanded further by solving the differential equations (5.1) and (8). 
Therefore, the solution of the ground truth model (Nelissen N, Warwick J & Dupont P 
at al., 2012) described in figure 1.1 is given by: 
𝐶𝑇(𝑡) = 𝐶𝐹+𝑁𝑆(𝑡) + 𝐶𝐵(𝑡)  = (∅1𝑒
−𝜃1𝑡 + ∅2𝑒
−𝜃2𝑡)  ⊗ 𝐶𝑃(𝑡)                                                (10) 
where: 
∅1 =
𝐾1(𝜃1 − 𝑘3 − 𝑘4)
∆
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∅2 =
𝐾1(𝜃2 − 𝑘3 − 𝑘4)
−∆
                                                                                                                     
𝜃1 =
𝑘2 + 𝑘3 + 𝑘4 + ∆
2
                                                                                                                       
𝜃2 =
𝑘2 + 𝑘3 + 𝑘4 − ∆
2
                                                                                                                      
∆= √(𝑘2 + 𝑘3 + 𝑘4)2 − 4𝑘2𝑘4                                                                                                       
This estimation is typically performed using a non-linear least square fitting approach.  
The quantity of interest is the binding potential BPND, which is the ratio of the 
concentration of specifically bound tracer in tissue to the concentration of non-
displaceable tracer in tissue. A commonly used quantitative approach is to define 
tracer binding in terms of distribution volume (DV) or VND (Kimura et al., 2007).  
VND is the distribution volume with no specific binding regions. VT is the total 
distribution volume. The relationship between BPND and the volumes of distribution is 
given by: 
𝐵𝑃𝑁𝐷 =
𝑉𝑇−𝑉𝑁𝐷
𝑉𝑁𝐷
=
𝑉𝑇
𝑉𝑁𝐷
− 1 = 𝐷𝑉𝑅 − 1
           
                                                     (11) 
where the term, 
𝑉𝑇
𝑉𝑁𝐷 
= 𝐷𝑉𝑅 = distribution volume ratio.                                     (11.1) 
For two-tissue compartment models, volumes of distribution can be derived from rate 
constants. The relationship of compartmental rate constants to the total volume of 
distributions given by: 
 
𝑉𝑇 =
𝐾1
𝑘2
(1 +
𝑘3
𝑘4
)      (unit-less) in a region containing the receptors of interest     (12) 
and 
 
 
𝑉𝑁𝐷 =
𝐾1
𝑘2
       (unit-less) in a reference region void of these receptors.                  (13) 
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1.3   The description of the various models used in 18F-fallypride receptor- 
ligand quantification 
In this work, five models were compared, using a sixth model (2T4k) as the ground 
truth: (1) the Logan graphical analysis (LGA) with arterial blood sampling, (2) the 
Logan graphical analysis using a reference region (cerebellum) (Loganref), (3) the 
reference tissue model (RTM) using the cerebellum as reference region, (4) the 
simplified reference tissue model (SRTM) and (5) standardized uptake value ratios 
(SUVR) measured as the ratio of the activity in a region of interest and the activity in 
the cerebellum.  
The arterial blood sampling is used to determine the transport of the radioactive 
tracers’ washout and metabolism in PET studies (Sijbesma et al., 2016). The arterial 
blood sampling models, 2T4k and LGA are regarded as invasive methods.  
The receptor kinetics can be modelled without the need to measure the arterial input 
function using the reference region models. This means the arterial blood sampling 
and metabolite measurements can be avoided, making the reference region models 
non-invasive methods. If the reference model (non-invasive) compares well to the 
arterial blood sampling model (invasive), then the arterial blood sampling model can 
be replaced by the non-invasive procedure. The reference region models, Loganref, 
RTM, SRTM and SUVR are regarded as non-invasive methods. 
 
1.3.1   LGA with arterial blood sampling 
LGA (Logan et al., 1990) is used for tracers that have reversible binding to the 
receptors of interest and when a steady state is reached. Logan graphical analysis 
requires an arterial plasma input function of the intact tracer as a function of time, 
which can be obtained by arterial blood sampling.  
Intact tracer represents the unchanged or free fraction of authentic parent tracer in 
plasma which is not bound to plasma proteins. It is assumed to equal to 1 at the time 
of injection (t=0), this means there is 100% of the input concentration of the 
unchanged tracer with no metabolites present. 
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Under the conditions above, it is possible to find a linear relationship between two 
new variables  and depending on Cp and CT and the slope of this 
relationship is the total volume of distribution (VT): 
The following steps show how the mathematical equations for LGA with arterial blood 
sampling can be derived by integrating the first-order differential equations. As 
discussed before, these first-order differential equations are used to describe the 
behaviour of an administered 18F-fallypride in target tissues using three-compartment 
model of 18F-fallypride in figure 1.1. 
To find the solution for LGA with arterial blood sampling: 
The sum of Eq. (5.1) and Eq. (8) can be arranged to give 𝐶𝐹+𝑁𝑆(𝑡)  in Eq.  (14) and 
Eq.  (8) to give 𝐶𝐵(𝑡) in Eq. (15)  
𝐶𝐹+𝑁𝑆(𝑡) =
𝐾1
𝑘2
𝐶𝑃(𝑡) −
1
𝑘2
(
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
+
𝑑𝐶𝐵(𝑡)
𝑑𝑡
)                                                               (14) 
𝐶𝐵(𝑡) = (
1
𝑘4
)
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
−
𝐾1
𝑘2
𝐶𝑃(𝑡) + (
𝑘2+𝑘3
𝑘4
) 𝐶𝐹+𝑁𝑆(𝑡)                                                  (15) 
Substituting Eq. (14) into Eq. (9), the output is: 
𝐶𝑇(𝑡) = (1 +
𝑘2+𝑘3
𝑘4
) 𝐶𝐹+𝑁𝑆(𝑡) + (
1
𝑘4
)
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
−
𝐾1
𝑘4
𝐶𝑃(𝑡)                                            (16) 
Further substitution with Eq. (14) and rearrangements gives: 
𝐶𝑇(𝑡) =
𝐾1
𝑘2
(1 +
𝑘3
𝑘4
) 𝐶𝑃(𝑡) −
1
𝑘2
(1 +
𝑘3
𝑘4
) [
𝑑𝐶𝐹+𝑁𝑆(𝑡)
𝑑𝑡
+
𝑑𝐶𝐵(𝑡)
𝑑𝑡
] −
1
𝑘4
𝑑𝐶𝐵(𝑡)
𝑑𝑡
                          (17) 
The integrated form of this equation is:  
∫ 𝐶𝑇(𝑡)
𝑇
0
=
𝐾1
𝑘2
(1 +
𝑘3
𝑘4
) ∫ 𝐶𝑃(𝑡)
𝑇
0
−
1
𝑘2
(1 +
𝑘3
𝑘4
) [𝐶𝐹+𝑁𝑆(𝑡) + 𝐶𝐵(𝑡)] −
1
𝑘4
𝐶𝐵(𝑡)                (18) 
Dividing Eq. (16) by 𝐶𝑇(𝑡) gives: 
∫ 𝐶𝑇(𝑡)
𝑇
0
𝐶𝑇(𝑡)
= (
𝐾1
𝑘2
(1 +
𝑘3
𝑘4
))
∫ 𝐶𝑃(𝑡)
𝑇
0
𝐶𝑇(𝑡)
−
1
𝑘2
(1 +
𝑘3
𝑘4
)
[𝐶𝐹+𝑁𝑆(𝑡)+𝐶𝐵(𝑡)]
𝐶𝑇(𝑡)
− (
1
𝑘4
)
𝐶𝐵(𝑡)
𝐶𝑇(𝑡)
                        (19) 
Rearrangement of Eq. (19) gives: 
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∫ 𝐶𝑇(𝑡)
𝑇
0
𝐶𝑇(𝑡)
= (
𝐾1
𝑘2
(1 +
𝑘3
𝑘4
))
∫ 𝐶𝑃(𝑡)
𝑇
0
𝐶𝑇(𝑡)
−
1
𝑘2
(1 +
𝑘3
𝑘4
) − (
1
𝑘4
)
𝐶𝐵(𝑡)
𝐶𝐹+𝑁𝑆(𝑡)+𝐶𝐵(𝑡)
                                 (20) 
The condition for linearity of Eq. (20) is that the intercept 
−
1
𝑘2
(1 +
𝑘3
𝑘4
) − (
1
𝑘4
)
𝐶𝐵(𝑡)
𝐶𝐹+𝑁𝑆(𝑡)+𝐶𝐵(𝑡)
 is constant. After some time t>t*, the compartment 
concentrations follow the plasma concentration so that 
𝐶𝐹+𝑁𝑆(𝑡)+𝐶𝐵(𝑡)
𝐶𝑃(𝑡)
 and 
𝐶𝐵(𝑡)
𝐶𝑃(𝑡)
 are 
constant, which ensures that the intercept is constant since 𝐶𝑃(𝑡) cancels. In many 
cases the intercept becomes constant even before 
𝐶𝐹+𝑁𝑆(𝑡)+𝐶𝐵(𝑡)
𝐶𝑃(𝑡)
 becomes constant so 
that the graphical method can be applied before the steady-state condition becomes 
valid. 
If distribution volume, 𝑉𝑇 = 𝐷𝑉 =
𝐾1
𝑘2
(1 +
𝑘3
𝑘4
), and the intercept is marked with A, the 
Logan plot can be represented as: 
                                                                                    (21)
 
where A is regarded as a constant if  remains constant after a certain time t*. By 
calculating this relationship for all time frames after time t*, VT can be determined by 
linear regression. 
  
1.3.2   Loganref using a reference region (cerebellum) 
If the metabolite corrected plasma curve is not available, but instead a reference 
region can be found which is void of the receptors of interest, Logan graphical 
analysis using a reference region can be applied under the same conditions as the 
classical Logan graphical analysis (Logan et al., 1996): 
                                                                               (22)
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where the distribution volume ratio (DVR) is the ratio of the volume of distribution in 
the region of interest and the reference region. B is regarded as a constant if   
remains constant after some time t* (Wong et al., 2012). The relation between DVR 
and BPND can be found by re-arranging equation (11): 
DVR = 1+BPND                                                                                                         (23)
                                                                            
 
For 18F-fallypride the cerebellum was used as reference region for all models that 
require this. The cerebellum is a structure in the brain with very low D2\D3 receptor 
density (Christian et al., 2006). 
 
1.3.3   Reference tissue model 
The RTM in (figure 2.1) assumes that: 
1) The regions of interest and the reference region share the same arterial input 
function (Lammertsma et al., 1996; Watabe et al., 2006);  
2) A reference region which is void of the receptors of interest can be found;  
3) The DV of free ligand in tissue in the region of interest and the reference region is 
the same i.e. in the target region and in the reference region the relation following 
relationship holds. 
𝐷𝑉 =  𝑉𝑁𝐷 =
𝐾1
𝑘2
=
𝐾1
𝑟𝑒𝑓
𝑘2
𝑟𝑒𝑓                                                                                          (24) 
When these assumptions are met, the model does not require an arterial input 
function. This means the reference region is then used as an indirect input function to 
the total target region.  
ref
T
C
C
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Figure 2.1: Reference tissue model 
 
The operational equation of the reference tissue model (Lammertsma, 1996) is:  
                                                                    (25)
 
Where 
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⊗ = convolution 
Using non-linear fitting the equation can be used to obtain four parameters namely 
(R1, k2, k3, and k4), and BPND can be calculated as: 
 .
                                                                                                                (26)
 
For 18F-fallypride, the cerebellum will be used as reference region (Christian et al., 
2006). 
 
1.3.4   Simplified reference tissue model 
The SRTM is a further simplification of the RTM by assuming that in the receptor-rich 
tissue of interest, it is not easy to differentiate between specific and the free/non-
specific compartment and as result of this, it can be described by a single tissue 
compartment. The other assumptions of the RTM are required as well.  
When the SRTM is appropriate, it produces more stable results and smaller standard 
errors compared to the RTM, because it reduces the number of parameters to be 
estimated from four to three. 
 
The operational equation of the simplified reference tissue model (Lammertsma and 
Hume, 1996) is:  
                                                        (27)
 
where  represents the time activity curve (TAC) in the region of interest and 
 is the TAC in the reference region (in our case the cerebellum).  
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The three parameters (R1, k2, BPND) in the equation above can be fitted using 
standard nonlinear estimation techniques.  
1.3.5   Standard uptake value ratio 
SUVR is measured as the ratio of the activity in a region of interest and the activity in 
the reference region, which is the cerebellum in our study. SUVR is a dimensionless 
quantity which is easy to calculate and which does not depend on scaling factors 
related to the scanner or the patient (van den Hoff et al., 2013; McNamee et al., 
2009). 
As explained by McNamee et al (2009), the equation of the SUVR can be written as 
follows.  
                                                                                 (28)
 
Where 𝐶𝑅𝑂𝐼 and 𝐶𝑅𝐸𝐹 are the activities in the region of interest and cerebellum 
respectively between the time t1 and t2. 𝑆𝑈𝑉𝑅𝑂𝐼 and 𝑆𝑈𝑉𝑅𝐸𝐹 are the SUV values 
(Pavlopoulos et al., 2007), (Kinahan et al., 2010). SUVR will be measured in different 
time intervals (McNamee et al., 2009).  
 
1.4   The use of simulations in kinetic modelling 
Modeling and simulation provide more detailed depth of theoretical and experimental 
analysis on the issues that are impractical to solve. They supplement theory and 
experimentation, improving the scientific method. 
The number of researchers employing simulations to analyze data is increasing. It is, 
however, very important that this kind of simulations are fully understood.  
Kinetic modelling simulation involves the following basic steps as stated by Resat et 
al., (2009): Identification of the kinetic modelling problem which involves the 
determination of the input and output variables as well as the intermediates, model 
formulation, choosing a method, simulation, and studying the sensitivity to parameter 
variations. 
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1.5   The use of the graphical and simplified methods in 18F-fallypride 
quantification and their importance in kinetic modelling 
Graphical and/or simplified methods are used for quantifying brain PET data because 
they are quantitatively accurate, thus producing fast and simplified calculation 
methods or less invasive procedures. Even though the arterial blood sampling is 
used to determine the transport of the radioactive tracers’ washout and metabolism in 
PET studies (Sijbesma et al., 2016), the main advantage of using the simplified 
methods is to eliminate the need to perform arterial blood sampling. Quantitative 
accuracy can be achieved while maximizing patient comfort. (Salinas et al., (2015). In 
case of 18F-fallypride, the cerebellum can be used as a reference region due to its 
low density of D2 and D3 receptors (Christian et al., 2006). The main advantage of 
graphical methods is that they are easy to use, simple to implement and fast and 
therefore ideally suited for parametric imaging in which we perform voxel based 
kinetic modelling (Kimura et al., 2007). 
 
1.6   Problem Statement and research impact 
Several simplified methods of quantifying 18F-fallypride have been described and 
used on real data, but a systematic analysis of their effect on quantification has not 
been performed. 
While performing simplified methods of quantification of 18F-fallypride, simulations are 
useful for the tracer in question, because they allow the study of different models and 
approaches under fully controlled conditions and also provide a ground truth. 
Simulation involves the calculation of solving the equations for the ‘ground truth’ 
model (figure 1.1) given a perfect input function Cp(t) with a given set of parameters. 
This leads to the ground truth parameters of interest.  
Simulating the dynamic PET data plays an important role in the validation of model 
analysis and the software development. 
The general idea is that with known “flawless” input data, a model and a set of model 
parameters, a flawless tissue curve can be calculated. This can be done for any time 
point (within the time interval of the input function).  
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A real PET experiment will consist of a dynamic measurement using a number of 
frames with defined duration. This means that the tissue curve is sampled according 
to the frame definition. Furthermore, PET data contains noise, which depends on the 
amount of tracer in the region of interest, the duration of the frame and the decay of 
the tracer.  
The parameters of interest of each simplified model were calculated using 
realistically simulated PET data as the measurement and were compared with the 
ground truth results.  
 
1.7   Aim and Objectives of the study 
The aim of this study is to investigate simplified methods to quantify 18F-fallypride, 
and to study the impact of different acquisition protocols on this quantification by 
using simulations. 
Specific objectives of the study: 
1. To evaluate the accuracy/reliability of various models in18F-fallypride 
quantification.  
2. To investigate the effect of models performance under varying noise-
level/signal to noise ratio (SNR) in brain regions with high, moderate, and low 
receptor density  
3. To investigate the effect of models performance under varying conditions in 
brain regions with high, moderate, and low receptor density such as: 
a) Total scan duration (continuous sampling scheme) 
b) Scan duration with breaks (interrupted sampling scheme) 
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Chapter 2: Literature Review  
2.1   Introduction 
The search and selection strategy of the literature review was based on a search 
using comprehensive search keywords (Fallypride, simulation, kinetic modelling, 
positron emission tomography OR PET, D2/D3 receptors, binding potential). The 
database on PubMed and other internet resources (from 1970 to 2018) were used in 
this study. Only those publications in peer-reviewed journals in English language 
were considered. 
Abstracts were collected based on how relevant they are to our study. 
2.2   The use of fallypride PET in neurological and psychiatric diseases 
Extrastriatal DA plays a very important role in human cognition/behavior which is 
implicated in a number of neurological and psychiatric diseases, including 
Parkinson's disease, Huntington’s chorea, schizophrenia, and psychostimulant 
dependence syndromes to name few. Several radiopharmaceuticals have been 
targeted to different areas in the brain in order to study the nature of these various 
diseases.  
As described by Riccardi et al (2006), there are several radioligands used to 
measure DA D2 receptor levels in the striatum, such as 
11C-raclopride, and 123I-IBZM.  
High-affinity radioligands, such as 11C-FLB 457, 123I-epidepride, and 18F-fallypride are 
used to visualize DA D2/D3 receptors in striatal and extrastriatal regions. However, 
11C-FLB 457 and 123I-epidepride have prolonged striatal uptake, which makes it 
difficult to estimate striatal DA D2/D3 receptor levels. 
18F-fallypride, on the other hand, 
has relatively slow kinetics and more rapid washout from striatum, which makes it 
easy to estimate striatal DA D2/D3 receptor levels (Riccardi et al., 2006; Zald et al., 
2010; Ceccarini et al., 2012). This makes it suitable to use in neurological and 
psychiatric diseases. 
The affinity of 18F-fallypride to DA D2 and D3 receptors is comparable to that of [
11C]-
FLB457, and some 10-fold higher than the affinities of 11C-raclopride or 11C- (1)-
PHNO (Cumming et al., 2013).  
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There is an interest in fallypride PET for various reasons. Some of these reasons 
include its use and application in neurological and psychiatric diseases, which has 
accelerated over the years. 
  
2.2.1   The choice of reference tissue models in 18F-fallypride human experiments 
studies 
Work relevant to our research has already been performed by Salinas et al., (2015), 
Ishibashi et al., (2013) and Slifstein et al., (2010) using simplified models with 
fallypride tested on humans.  
Below is what has been done and concluded, applying these models using optimizing 
protocols, while taking into consideration the selection or the best model for 
quantification of fallypride. 
2.2.1.1   Simplified reference tissue model 
Reference tissue models (less invasive procedures) have been used in last the two 
decades as the methods of choice for the quantification of brain PET (Salinas et al 
2015). They can be used to eliminate arterial blood sampling, which requires blood 
measurements and metabolite concentrations for input function generation.  
 
SRTM assumes that tracer activity exchange between tissue compartments can be 
described by a 1-tissue compartment model. This reduces the number of parameters 
to three, hence allowing precise accuracy in mapping (BPND). 
 
The three parameters produce more accurate fitting of kinetic data, resulting in stable 
parameter estimation. Due to its simplicity the model can produce a good fit, which 
can affect the estimates of the binding potential (BPND) (Salinas et al., 2015).  
In their study Salinas et al., (2015) used computer simulation to study the bias 
introduced in BPND estimates by violating the model assumptions. Their study 
showed that violating the model assumptions led to bias in BPND (both over and 
underestimation).  
Their conclusion was that the bias found in SRTM BPND should be carefully assessed 
when using new radiotracers (Salinas et al 2015). 
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Using the simplified reference tissue model, Ishibashi et al., (2013) investigated the 
influence of reference region choice on the striatal binding potential of a high-affinity 
DA D2/D3 receptor radioligand (
18F-fallypride). Comparison was made between the 
use of the visual cortex and a white matter to the cerebellum (used as reference 
region). In comparison to cerebellum, visual cortex gave greater sample variance in 
BP relative to BPND. The results showed that BPND values in white matter produced 
similar results as the BPND values cerebellum. 
The study suggests white matter to be used as an alternative to the cerebellum due 
to similar kinetic properties (Ishibashi et al., 2013). 
 
18F-fallypride BPND was calculated by Siessmeier et al., (2005) using a 2-tissue 
compartment model, Logan method using metabolite-corrected arterial inputs, Logan 
reference tissue method, conventional simplified reference tissue method (SRTM), 
and SRTM with linear regression and spatial constraint (LRSC). It was found that the 
ratio of BP in the striatum to that in the thalamus was much higher for 18F-fallypride 
(Siessmeier et al., 2005).  
The BP’s coefficient of variation was found to be less favourable for 18F-fallypride in 
the striatum (dopamine receptor rich region). Siessmeier et al., (2005) reported that 
the very slow approach when it comes to 18F-fallypride equilibrium binding may affect 
the accuracy in estimating striatum BP, even for long 4 hour scans.  
Slifstein et al., (2010) used 18F-fallypride to measure the effects of amphetamine on 
D2/D3 ligand binding in striatum and extra-striatal brain regions in one scan session.  
The two tissue compartment model (2T4k) with arterial plasma input and simplified 
reference tissue model (SRTM) were used to analyze PET data.  
It was found that the estimated amount of the decreases in BPND amphetamine effect 
tend to be greater with 2T4k than SRTM method.  
It was concluded that 18F-fallypride is a suitable for measuring the effect of 
amphetamine in striatum and limbic regions, but in cortical regions (Slifstein et al., 
2010). 
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2.2.1.2   Application of SRTM focusing on total scan duration 
The available antagonist radioligands for quantitation of extrastriatal DA D2/D3 
receptors all have strengths and limitations. 18F-fallypride can be used to estimate DA 
D2/D3 receptor levels in both striatal and extrastriatal regions but requires about 3–
3.5 hours of scanning (Vernaleken et al., 2011; Riccardi et al., 2006, 2011). 
Vernaleken, et al., (2011) investigated the applicability of a simplified reference tissue 
model (SRTM) when the scan duration was changed in a large sample of PET scans. 
Subjects were scanned using fallypride for 180 min scan duration. SRTM was used 
to calculate the binding potential (BPND) for putamen, thalamus, and temporal cortex. 
Shortening the scan time duration caused BPND underestimation to escalate from 
0.58% in 10 min to 5.76% in 1 hour (Vernaleken, et al., 2011). For 18F-fallypride, it 
was found out that 180 min scan duration reached equilibrium even in D2/D3 receptor 
rich regions. 
Moderate reductions in fallypride scan durations only caused small changes to SRTM 
results even in receptor rich regions. Their results correlated with the data published 
by Riccardi et al., (2006, 2011), stating that 18F-Fallypride requires about 3 – 3.5 
hours of scanning. 
Furthermore, in their study, Constantinescu et al., (2011), used the maximum scan 
time of up to 2.5 hours for 18F-fallypride studies. The results revealed the stability in 
18F-fallypride kinetics at 2.5 hours, which can be an advantage to human studies. 
Such reduced acquisition times and imaging protocols aim to balance quantitative 
accuracy between patient comfort and image artefacts due to possibility of patient 
motion during acquisition. 
Honer et al., (2004) estimated BPND as a function of scan duration using 
18F-fallypride 
with 2.5 hours scanning time. Tantawy et al., (2009) used the total scan duration of 2 
hours estimated BPND. 
Ishibashi et al., (2013) stated that 18F-fallypride has relatively slow kinetics, thus 
requiring a prolonged scanning time of at least 2 to 3 hours. 
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2.2.1.3   Logan reference tissue model 
Loganref yields a parameter (DVR) that is proportional to specific binding. The method 
assumes the existence of a reference region which is incorporated rather than the 
arterial blood radioligand concentration (Logan et al., 1996; Mukherjee et al., 2001).  
2.2.1.4   RTM 
RTM can be used as an alternative method to eliminate the use of invasive arterial 
blood sampling (Ishibashi et al., 2013). 
To our knowledge, the reference tissue model (RTM) using the cerebellum as the 
reference region is not yet studied for fallypride, but has been for other tracers. 
2.2.1.5   SUVR 
Arterial blood sampling, dynamic imaging and kinetic modeling are regarded as the 
‘gold standard’ for quantification of PET measurements. Kinetic modeling techniques 
play an important role in replacing the blood data with the data from a reference 
region, thus further simplifications such as calculation of standard uptake value ratios 
(SUVR) act as a replacement for kinetic modeling (Gunn et al., 2015) which reflects 
the relative contribution of specific and non-specific binding as represented by the 
reference region and it does not require arterial blood sampling or long scanning 
durations (Heurling et al., 2017).  
However, to determine whether SUVR truly reflects true quantification, it has to be 
validated against the quantitative gold standard (Gunn et al., 2015; Heurling et al., 
2017). SUVR has thus far been the most widely used with different tracers ([18F]-
AV45 PET, [11C]-PiB PET, T807 (tau) (20), florbetapir (Aβ), [18F]THK-5117) other 
than fallypride (Blautzik et al., 2017; Brier et al., 2016; Ishiki et al., 2015). 
2.3   Simulations in kinetic modelling 
The uptake and washout of a tracer in a tissue region depends on physiological and 
biochemical parameters which can be quantified by analyzing TACs obtained from 
dynamic PET. 
Kinetic modelling simulation is used to study the kinetics of tracers. It can be used to 
determine the input and output functions, model formulation, choosing a method, 
simulation, and studying the sensitivity to parameter variations (Resat et al., 2009) 
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2.3.1   Simulation of the input function  
The simulation of the input function includes methods like linear interpolation 
between the measured points, spline fitting and mathematical function fitting using 
the sum of exponential functions, a Thompson and Golish bolus input function 
(Thompson et al., 1964; Golish et al., 2001) or a Gamma variate (Davenport et al., 
1984; Madsen, 1992). 
Several studies have simulated the input function using the sum of exponential 
functions. 
Ito et al., (1998) used 11C-raclopride with a three-compartment model, and simulated 
the input function as an interpolation of a sum of two exponential functions with time 
interval of 3.5 to 60 minutes (0 to 3.5 minutes, linear interpolation). Since the kinetic 
method requires determination of an arterial input function, it was concluded that the 
transient equilibrium method and the interval method used in the study are suitable 
for routine clinical research, because they do not require determination of an arterial 
input function. 
A direct comparison of 18F-fallypride and 11C-FLB457 using the multiple-injection 
protocol was performed by Vandehey et al., (2010). TACs were fitted with the sum of 
three exponents to describe the decline of the radiotracer. The rate of clearance 
between 11C-FLB457 and 18F-fallypride were compared. 
2.3.2   Simulation of the Time Activity curves   
Ceccarini et al., (2012) used 18F-fallypride PET to detect striatal and extrastriatal  
dopamine release using human and simulation studies. PET data was analyzed 
using the linearized simplified reference region model. The noiseless TACs of 18F-
fallypride were generated using simulations. The simulations were performed using 
extended standard compartmental model commonly used in tracer kinetic PET 
analysis (Ceccarini et al., 2012).  
 
The concentration of the plasma input function was modeled by biexponential decay 
function. Time–activity curves were simulated using the rate constants of 18F-
fallypride based on Christian et al., (2004).  It was found that the effect of striatal 
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dopamine release could be detected if the activation starts between 190 to 200 
minutes after injection using the linearized simplified reference region model. 
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Chapter 3: Methods 
3.1   Research design and material used 
The study was conducted at Tygerberg Academic Hospital in the department of 
Medical Imaging and Clinical Oncology (MICO) of Stellenbosch University. 
In this study 18F-fallypride kinetics in the human brain were investigated using 
simulations. All simulations were performed using Matlab (version R2013a 
(8.1.0.604) win 64-bit software; MathWorks, Inc.) and the software developed at KU 
Leuven (Belgium). 
The Matlab scripts were further adapted for the current study. 
Simulations of realistic measurements were performed by: 
1). Simulation/modelling of a representative input function 
2). Modelling the fraction of intact tracer 
3). Simulation of the theoretical output function (TAC) in brain regions with high,  
     moderate and low receptor density  
4). Simulation of the measurement noise by Gaussian noise model 
 
Different analysis methods (LGA, Loganref, RTM, SRTM and SUVR) were tested with 
the simulated tissue data. The ability of each method to reproduce the model 
parameters, or distribution (the parameter associated with the physiological drug 
uptake) was then assessed.  
3.2   Research methodology 
3.2.1   Simulation/modelling of a representative input function 
A representative curve of arterial blood plasma input function after a bolus 18F-
fallypride administration (figure 3.1) was taken from the literature (Mukherjee et al., 
2002).  
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Figure 3.1: A representative curve of arterial blood plasma levels of fluorine-18 radioactivity after a 
bolus 
18
F-fallypride administration. The inset shows the peak in the first 12 minutes. Reprinted with 
permisson from Mukherjee, J., Christian, BT, Dunigan KA., Shi, B, Narayanan, TK, Satter, M, & Mantil, 
et al. Brain imaging of 
18
F-fallypride in normal volunteers: Blood analysis, distribution, test-retest 
studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. 
Synapse, 2002;46(3), 170–188. Copyright 2002, John Wiley & Sons Inc. 
A representative input function curve in figure 3.1 was used to reproduce a simulated 
input function using Matlab (refer to figure 3.2 (A) and (B)). 
 
Figure 3.2: (A) A simulated curve of arterial blood plasma activity concentration of fluorine-18 
radioactivity after a bolus 
18
F-fallypride administration. (B) The inset shows the peak in the early 
section of the of the arterial blood plasma curve in the first 12 minutes. (Note: the concentration 
peaked before 3 min).  
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A typical arterial plasma input function after a bolus injection will have a short interval 
after the start of the injection (at t = 0) where no activity has reached the brain, 
followed by a sharp rise to a peak (arrival of the bolus in the brain) and then a rapid 
decline and levelling off of the arterial plasma concentration. Therefore, the input 
function (figure 3.2) was modelled as follows:  
                                                                                                                                 (29) 
where Ca(t) is the arterial plasma activity concentration, ts is the time when the bolus 
reaches the brain and tp is the time of the peak concentration of the bolus in the 
brain. After a short delay ts, the increase in concentration is modelled as a linear 
increase until reaching the peak value, followed by behaviour which is modelled as a 
sum of 3 exponentials with different biological decay constants βi and amplitudes Ai.  
The parameters of this model were chosen in such a way that the simulated input 
function (figure 3.2) resembles a true input function (figure 3.1).  
 
When selecting the parameters ts = 0.35 min, tp = 0.7 min, A = [27.50 7.50 0.925] 
kBq/ml, β = [0.1 1.2 100] min, an input function is obtained which is similar to that in 
figure 3.1, as seen in figure 3.2. Note that the parameter A, expressed in kBq/ml was 
converted to nCi/cc to enable comparison of figures 3.1 and 3.2. The unit kBq/ml is 
otherwise used in this thesis. 
The input function defined by selecting the parameters above, represents the 
concentration of 18F (fraction of the intact tracer and metabolites) in plasma as a 
function of time. 
The fraction of the intact tracer represents the unchanged or free fraction of authentic 
parent tracer in plasma which is not bound to plasma proteins. It is assumed to equal 
to 1 at the time of injection (t=0), this means there is 100% of the input concentration 
of the unchanged tracer with no metabolites present. 
ttifeA
tttiftt
tt
A
ttif
p
i
tt
i
pss
sp
i
i
s
i
p










3
1
))(2ln(
3
1 )(
0

 
)(tCa
Stellenbosch University  https://scholar.sun.ac.za
 48 
 
Metabolites refer to a specific series of reactions that the trace will undergo once 
injected in the body. The tracer will be broken down or metabolised into a different 
substances which leads to the logical changes to a parent compound. 
 Note that the input function is decay corrected to the time of injection. 
 
3.2.2   Modelling the fraction of the intact tracer 
The fraction of metabolites of 18F-fallypride in arterial plasma, based on experimental 
data is plotted as a percentage of the intact fraction in figure 3.3 (Mukherjee et al., 
2002). The fraction of intact tracer starts with a value of 1 at the time of injection 
which means that no metabolites are present initially. It gradually decreases as 
metabolites accumulate. 
 
Figure 3.3: Fraction of intact 
18
F-fallypride tracer in arterial plasma as function of time after injection 
Reprinted with permisson from Mukherjee, J., Christian, BT, Dunigan KA., Shi, B, Narayanan, TK, 
Satter, M, & Mantil, et al. Brain imaging of 
18
F-fallypride in normal volunteers: Blood analysis, 
distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine 
D-2/D-3 receptors. Synapse, 2002;46(3), 170–188. Copyright 2002, John Wiley & Sons Inc. 
The fraction of intact 18F-fallypride tracer in arterial plasma (figure 3.3) was used to 
create a simulated fraction of intact tracer (figure 3.4). 
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Figure 3.4: Simulated fraction of intact 
18
F-fallypride tracer in arterial plasma as function of time after 
injection. 
To model the intact fraction of the tracer, the following function was used:  
                                                            (30) 
The parameter “b” was set to b = 1, assuming that at time 0 the input concentration 
consists of 100% intact tracer. The parameter n determines the steepness of the 
slope and should be negative, and “a” is the time when the function reaches half of 
its maximum (b/2). 
 
In figure 3.4, the simulated intact fraction of tracer is based on Eq. 31 using b = 1, a 
=70 min, n = -0.6. 
Metabolites of fallypride that are created outside the brain were assumed to not cross 
the blood-brain-barrier, in which case the input function (Eq. 29) needs to be 
multiplied by the intact fraction (Eq. 30) which gives: 
 𝐶𝑎(𝑡)𝑐𝑜𝑟𝑟 = 𝐹(𝑡) ∗ 𝐶𝑎(𝑡)                                                                                           (31)                    
where  𝐶𝑎(𝑡)𝑐𝑜𝑟𝑟 is the input function corrected for the intact fraction, 𝐹(𝑡) is the intact 
fraction and 𝐶𝑎(𝑡) is the input corrected for decay to the time of injection from Eq. 29. 
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3.2.3   Simulation of the theoretical output function (TAC) in brain regions with high, 
moderate and low receptor density 
The 2T4k model of 18F-fallypride was considered as the ground truth model (refer to 
figure 1.1). 
Four different VOI’s in the brain with different kinetic behaviour were used: putamen, 
thalamus, temporal cortex and cerebellum. For each VOI, ground truth values were 
taken from the literature (Christian et al., 2004). Values were not available for the 
human brain and therefore values were selected from non-human primate brain data 
for the simulations. Note that the data from Mukherjee et al., (2002) obtained from 
human data, was only used as the representative curve of arterial blood plasma input 
function. 
A similar strategy is used in other human brain imaging studies (Vandehey et al., 
2010; Morris et al., 2007).  
Table 3.1 Four rate constants for different VOIs taken from Christian et al., 2004. 
Rate constant Putamen Thalamus Temporal cortex Cerebellum 
K1 (min
-1) 0.17 0.14 0.24 0.33 
k2 (min
-1) 0.21 0.26 0.24 0.42 
k3 (min
-1) 0.108 0.187 0.026 0.0097 
k4 (min
-1) 0.043 0.056 0.043 0.043 
Based on the parameters selected and using 2T4k model, ideal concentration-time 
curves were generated for the four different VOI’s using a modelled input function 
corrected for decay and intact tracer. These are shown in figures 3.5 (A – D). 
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Figure 3.5: Ideal output function for the putamen (A), thalamus (B), temporal cortex (C) and 
cerebellum (D) 
 
3.2.4   Simulation of the measurement noise by Gaussian model 
Noise was added to the sampled PET output to obtain realistic simulations. To add 
noise, the physical decay of the isotope was first modelled and noise was then added 
to this value using a Gaussian noise model with zero mean (μ = 0) and standard 
deviation (σ).  
                                   
 (Logan et al., 2001)                                      (32) 
 Cuncor(i) is the average counts in a VOI during frame i before decay correction and Δti 
is the duration of frame i. The parameter f controls the amount of noise. To 
investigate the effect of signal to noise we have used f = 0.05, 0.15 and 0.25 
representing low, moderate and high noise respectively 
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In our study we took a more realistic approach and looked at the effect of noise 
based on the acquisition described by Dunn et al., (2013) which corresponds to 
sampling scheme (i) in this study (refer to section 3.2.5). We tested if the simplified 
models perform well enough and if they can be used to avoid arterial blood sampling. 
This depends on the amount of noise applied. We specified the noise model by 
varying the fraction of noise level using f = 0.05, 0.15 and 0.25.  
 
3.2.5   Specifying the scan duration with continuous and interrupted sampling 
schemes  
In reality, a fallypride scanning session can last 3 hours or more. The advantage of a 
simulation is that it can go up to even longer scanning times without artefacts being 
created by patient movement.  
In this work two different sampling schemes ((i) continuous sampling scheme (ii) 
interrupted sampling scheme) with different total scan duration were simulated.  Both 
sampling schemes consisted of a common part which covers the first 30 minutes, 
measured using the following frame definition: 4 x 15s; 4 x 60s; 2 x 150s; 4 x 300s to 
capture the rapid changes in concentration as a result of the bolus injection to match 
real-world sampling constraints. The continuous sampling scheme consisted of this 
common part followed by additional frames of 5 minutes until the end of the scan. 
The total scan duration was varied between 30 minutes and 240 minutes as follows: 
30 minutes, 1 hour, 1.5 hours, 2 hours, 2.5 hours, 3 hours, 3.5 hours, and 4 hours. 
An interrupted sampling scheme (containing breaks) during which the patient can be 
taken out of the scanner was simulated using a series of 10 different interrupted 
sampling schemes tabulated in (Table 3.2 and Table 3.3). These interrupted 
sampling schemes consisted of the common part (first 30 minutes) followed by 5 
minutes frames until 240 minutes post injection but with inclusion of breaks of 60, 
120 or 180 minutes or by including two breaks.  
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Table 3.2 Different interrupted sampling schemes (1hour break) 
Sampling  
number 
Interrupted sampling scheme Total scan 
time 
1  
 
 
180 minutes 
2  
 
 
180 minutes 
3  
 
 
180 minutes 
4  
 
 
180 minutes 
5  
 
 
180 minutes 
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Table 3.3 Different interrupted sampling schemes (2 to 3 hours break) 
Sampling  
number 
Interrupted sampling scheme Total scan 
time 
6  
 
 
120 minutes 
7  
 
 
120 minutes 
8  
 
 
120 minutes 
9  
 
 
60 minutes 
10  
 
 
90 minutes 
 
To obtain integrals of the time activity curves, simple trapezoidal integration with a 
step size of 0.001 min was used. 
The final sampled PET output is the theoretical output function measured at the 
midscan time of each frame as is usually done in dynamic PET measurements, with 
the addition of noise.  
Modelled data including sampling and noise for the four different VOIs at three 
different noise levels for the full 240 minutes are shown in figures 3.6 to 3.9.  
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Figure 3.6: Modelled data for the putamen at three noise levels using continuous sampling scheme 
with scan duration of 240 minutes. 
 
 
 
 
 
 
 
0 20 40 60 80 100 120 140 160 180 200 220 240
0
1
2
3
4
5
6
Putamen (f=0.05)
time in min
k
B
q
/m
l
0 20 40 60 80 100 120 140 160 180 200 220 240
0
1
2
3
4
5
6
Putamen (f=0.15)
time in min
k
B
q
/m
l
0 20 40 60 80 100 120 140 160 180 200 220 240
0
1
2
3
4
5
6
7
time in min
k
B
q
/m
l
Putamen (f=0.25)
Stellenbosch University  https://scholar.sun.ac.za
 56 
 
  
 
Figure 3.7: Modelled data for the thalamus at three noise levels continuous sampling scheme with 
scan duration of 240 minutes. 
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Figure 3.8: Modelled data for the temporal at three noise levels using continuous sampling scheme 
with scan duration of 240 minutes. 
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Figure 3.9: Modelled data for the cerebellum at three noise levels using continuous sampling scheme 
with scan duration of 240 minutes. 
 
3.2.6   Volume of distribution 
The parameters of interest include the total volume of distribution (VT) and the volume 
of distribution ratio (DVR) taking the cerebellum as the reference. These values can 
be calculated from the ground-truth rate-constants. Based on these theoretical 
values, the following values were obtained which were used as a ground truth: VT 
(putamen) = 21.09; VT (thalamus) = 2.37; VT (temporal cortex) = 1.71; VT 
(cerebellum) = 0.97; DVR (putamen) = 21.71; DVR (thalamus) = 2.44; DVR (temporal 
cortex) = 1.76. In order to evaluate the different simplified models under investigation, 
a figure of merit was defined as the absolute error of the estimated VT or DVR with 
respect to the ground truth values, for the different settings under investigation.  
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3.3   The accuracy/reliability of various models in18F-fallypride quantification  
18F-fallypride binds to DA D2 and D3 receptors and is distributed in the brain in striatal 
and extrastriatal regions. These regions in the brain can be divided into “high”, 
“moderate” and “low” uptake regions depending on the receptor occupancy and the 
binding of 18F-fallypride in the brain as depicted in table 3.3. 
Putamen is classified as the “high” uptake region because of its high receptor 
occupancy, thus making 18F-fallypride easy to bind to DA D2/D3 receptors. 
Thalamus and temporal cortex can be classified as “moderate” and “low” uptake 
regions respectively, depending on the amount of DA D2/D3 receptors. 
 
The knowledge of the rate constants helps in optimizing the protocols for measuring 
small changes in DA D2/D3 receptor occupancy, Christian et al (2004) 
The process of measurements can alter the results. How far apart can 
measurements be without causing difficulties, is a question of judgment. 
To study the accuracy/reliability of various models, a range of possibilities was 
explored by varying the set rate constant values for putamen, temporal cortex and 
thalamus around those proposed by Christian et al (2004).  
This method introduces the probability of how far apart can rate constants be without 
deviating completely form the original values. It takes into account the small 
uncertainties in variation of rate constants. 
The fourth main VOI (cerebellum) served as the reference region (Slifstein et al., 
2004, Constantinescu et al., 2011, Christian et al., 2006, Ishibashi et al., 2013, 
Werhahn et al,. 2006).  
Simulations were performed up to 4 hours scan duration and the noise level for the 
reference region was set to f = 0.05.  
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 60 
 
Table 3.4 Different rate constants corresponding to VOIs with “high”, “moderate” or “low” uptake 
regions  
High uptake region (putamen) 
Rate 
constant 
set 
K1 
(min-1) 
k2 
(min-1) 
k3 
(min-1) 
k4 
(min-1) 
Rate 
constant 
set 
K1 
(min-1) 
k2 
(min-1) 
k3 
(min-1) 
k4 
(min-1) 
1 0.15 0.21 1.08 0.043 11 0.17 0.21 1.00 0.043 
2 0.16 0.21 1.08 0.043 12 0.17 0.21 1.04 0.043 
3 0.17 0.21 1.08 0.043 13 0.17 0.21 1.08 0.043 
4 0.18 0.21 1.08 0.043 14 0.17 0.21 1.12 0.043 
5 0.19 0.21 1.08 0.043 15 0.17 0.21 1.16 0.043 
6 0.17 0.19 1.08 0.043 16 0.17 0.21 1.08 0.037 
7 0.17 0.20 1.08 0.043 17 0.17 0.21 1.08 0.040 
8 0.17 0.21 1.08 0.043 18 0.17 0.21 1.08 0.043 
9 0.17 0.22 1.08 0.043 19 0.17 0.21 1.08 0.046 
10 0.17 0.23 1.08 0.043 20 0.17 0.21 1.08 0.049 
Moderate/low uptake region (thalamus and temporal cortex) 
Rate 
constant 
set 
K1 
(min-1) 
k2 
(min-1) 
k3 
(min-1) 
k4 
(min-1) 
Rate 
constant 
set 
K1 
(min-1) 
k2 
(min-1) 
k3 
(min-1) 
k4 
(min-1) 
1 0.12 0.26 0.187 0.056  21 0.22 0.24 0.026 0.043  
2 0.13 0.26 0.187 0.056  22 0.23 0.24 0.026 0.043  
3 0.14 0.26 0.187 0.056  23 0.24 0.24 0.026 0.043  
4 0.15 0.26 0.187 0.056  24 0.25 0.24 0.026 0.043  
5 0.16 0.26 0.187 0.056  25 0.26 0.24 0.026 0.043  
6 0.14 0.24 0.187 0.056  26 0.24 0.22 0.026 0.043  
7 0.14 0.25 0.187 0.056  27 0.24 0.23 0.026 0.043  
8 0.14 0.26 0.187 0.056  28 0.24 0.24 0.026 0.043  
9 0.14 0.27 0.187 0.056  29 0.24 0.25 0.026 0.043  
10 0.14 0.28 0.187 0.056  30 0.24 0.26 0.026 0.043  
11 0.14 0.26 0.147 0.056  31 0.24 0.24 0.018 0.043  
12 0.14 0.26 0.167 0.056  32 0.24 0.24 0.022 0.043  
13 0.14 0.26 0.187 0.056  33 0.24 0.24 0.026 0.043  
14 0.14 0.26 0.207 0.056  34 0.24 0.24 0.030 0.043  
15 0.14 0.26 0.227 0.056  35 0.24 0.24 0.034 0.043  
16 0.14 0.26 0.187 0.050  36 0.24 0.24 0.026 0.037  
17 0.14 0.26 0.187 0.053  37 0.24 0.24 0.026 0.040  
18 0.14 0.26 0.187 0.056  38 0.24 0.24 0.026 0.043  
19 0.14 0.26 0.187 0.059  39 0.24 0.24 0.026 0.046  
20 0.14 0.26 0.187 0.062 40 0.24 0.24 0.026 0.049 
Note: Compartmental model rate constant denotes the fraction of the total tracer that will leave the 
compartment per unit time (fractional clearance). It has the unit of inverse time i.e., the proportion of 
tracer molecules in a given compartment that will “move” to another compartment in one minute. 
For each VOI corresponding to a set of rate constants, TAC’s were generated and 
the theoretical distribution volumes (DV) and theoretical distribution volume ratios 
(DVR) were calculated similar as described for the main VOIs in this study. Noise 
was added as described before. The results of each model and the ground truth 
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values were compared using 1) a correlation analysis and 2) a Bland-Altman 
analysis. 
 
3.4   Methods of data analysis 
3.4.1   Regression and Correlation analysis 
Regression analysis is the first step to figure out if there is a relationship between two 
variables. 
To determine the accuracy/reliability of various models in18F-fallypride quantification, 
linear regression was then used to find a relationship of different models against the 
ground-truth values of DV and DVR. The analysis using different models is shown in   
Appendix. 
The correlation coefficient (r) was used as an indicator to obtain agreement between 
the results of the two variables. Since high correlation does not mean that the two 
methods agree, Bland-Altman analysis was introduced as an addition to interpret the 
results. 
3.4.2   Bland-Altman analysis 
The first step of Bland-Altman is to find the significant difference between two 
measurements i.e. to look if there is a variation from zero of the difference between 
two measurements. If the measurements differ from zero, the two measurements do 
not agree. 
Bias is calculated as the mean of the difference between the true values and the 
values measured by the model for DV or DVR i.e. bias = mean (diff).  The bias as 
proposed by (Bland and Altman 1986) helps in finding the degree of agreement 
between measurements. 
The difference is calculated as, diff = X-Y and the average value = (X+Y)/2. 
To determine the upper confidence limit, the standard deviation of the difference is 
multiplied by 1.96 and added to the mean difference. Therefore, the upper limit = [(σ 
x 1.96) +mean]. 
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To determine the lower confidence limit, the standard deviation of the difference is 
multiplied by 1.96 and subtracted from the mean difference. Therefore, the lower limit 
= [mean - (σ x 1.96)]. 
The constant bias is observed when there is an equal number of data points above 
and below the mean difference line (bias) on Bland-Altman plot. 
The proportional bias is observed if there are a huge number of points above the 
mean difference line (bias) on Bland-Altman. 
  
3.4.3   Relative error 
If the true value of the measured quantity is 𝑥 and the measured value is 𝑥0, then the 
relative error (%) is defined as 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑒𝑟𝑟𝑜𝑟(%) = 100 ∗ [
𝑥0−𝑥
𝑥
 ] = 100 ∗ [
𝑥0
𝑥
− 1]                                                  (33) 
Where, 𝑥0 is represented by  𝐷𝑉𝑚𝑒𝑡ℎ𝑜𝑑 or 𝐷𝑉𝑅𝑚𝑒𝑡ℎ𝑜𝑑 and 𝑥 is represented 𝐷𝑉𝑇𝑟𝑢𝑒 or 
𝐷𝑉𝑅𝑇𝑟𝑢𝑒 
3.5   Criteria for best method selection 
Three conditional criteria or benchmarks were used to determine if the method is 
appropriate to use.  
This is conducted with reference to the question of whether to accept or reject the 
method. To investigate these possibilities, the following criteria were used as a 
condition in selection of the best method: 
a). The relative bias must be within the predetermined threshold range of ±10%.  
b). The relative error must be within the predetermined threshold range of ±10%.  
c). Both 5th and 95th percentiles or variability must be within ±10% limits at any given 
point.  
Those methods that perform well according to the above chosen criteria were 
considered as the methods of choice. These criteria were applied to the remainder of 
all the research questions or the specific objectives of this study. 
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CHAPTER 4: Results 
4.1   The accuracy/reliability of various methods in18F-fallypride quantification  
Kinetic data generated with a noise fraction levels of 0.05, 0.15 and 0.25 were 
processed and analysed. The medium noise data (noise level fraction of 0.15) is 
presented in this section as data that lies between the low and high noise data. 
In this case, the data is presented in terms of correlation and Bland-Altman analysis 
(refer to the end of chapter 3 for description and appendix for Matlab scripts). 
Note that in all the cases, the units for DV and DVR are unit less.  
4.1.1   Brain region with high receptor density (putamen)  
The regression and Bland-Altman plots for the distribution volume (DV) for models 
which require blood sampling for 2T4k and Logan method are shown in figure 4.1. 
In the regression analysis plots, it was observed that most of the points fall on or 
close to the dotted line (line of identity) in figure 4.1. The true values of DV are 
therefore well estimated by applying these methods.  
 
 
 
 
 
 
Figure 4.1: Regression and Bland-Altman plots for the distribution volume (DV) in high uptake regions 
obtained by the 2T4k model (A(i) and A(ii)) and the Logan model (B(i) and B(ii)) compared to the 
ground-truth values.  
Both 2T4k and Logan have a constant bias. For a constant bias, the error made on 
Bland-Altman plot is independent on the value itself. 
The relative bias can also be calculated by dividing the bias by the average value of 
DV.  
 
 
A(i) A(ii) B(i) B(ii) 
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Compared to the actual values of DV, the bias is small with relative average biases of 
0.0% and 1.7% for 2T4k and Logan respectively. Variation is also small with 5th to 
95th percentile ranges of -2.0% to 1.9% for 2T4k, and -0.9% to 3.6% for Logan. 
 
The distribution volume ratio (DVR) is the ratio of the volume of distribution in the 
region of interest and the reference region. The plots of DVR calculated using 
invasive arterial blood sampling models ((2T4k, Logan) and non-invasive reference 
region models (RTM, SRTM, Loganref) are shown in figure 4.2. We also show SUVR 
calculated in the interval 215 min – 240 min for completeness (Figure 4.2 F (i) and F 
(ii)).  
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 65 
 
 
Figure 4.2: Regression and Bland-Altman plots for the distribution volume ratio (DVR) obtained in high 
uptake regions by the 2T4k model (A(i) and A(ii)), Logan model (B(i) and B(ii)), RTM (C(i) and C(ii)), 
SRTM (D(i) and D(ii)), Loganref (E(i) and E(ii)) and SUVR (F(i) and F(ii)) compared to the ground-truth 
values.  
 
In figure 4.2, most of the points fall on or close to the dotted line (line of identity) for 
different models in regression analysis plots. This implies the true values of DVR are 
well estimated by applying all the models with an exception to SUVR. SUVR values 
are much higher than the true values of DVR.  
Correlation analysis showed that the DVR values estimated by different models in 
high uptake regions were positively correlated with the true DVR values. A good 
correlation was observed with correlation coefficients (r) ≥ 0.98 in all regression 
analysis plots except for SUVR (r = 0.95). 
 
  
  
A(i) A(ii) B(i) B(ii) 
C(i) C(ii) D(i) D(ii) 
E(i) E(ii) F(i) F(ii) 
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 Table 4.1: Comparison of arterial blood sampling models (2T4k and Logan) and reference models 
(Loganref, RTM, SRTM, SUVR) for the description of 
18
F-fallypride in high uptake region (putamen) 
Arterial blood sampling models 
(invasive) 
r bias 5-
percentile 
95-
percentile 
average value 
(unit less) 
2T4k DV  0.99 0.00 -0.42 0.40 21.22 
Logan DV  0.98 0.35 -0.20 0.76 21.04 
2T4k DVR  0.99 0.34 -0.12 0.76 21.86 
Logan DVR  0.98 0.75 0.60 1.19 21.66 
Reference region models 
(non-invasive) 
r bias 5-
percentile 
95-
percentile 
average value 
(unit less) 
Logan REF DVR  0.98 1.55 0.84 2.08 21.26 
RTM DVR  0.99 1.05 0.44 1.48 21.51 
SRTM DVR  0.99 1.03 0.41 1.50 21.52 
SUVR 0.95 -35.2 -38.90 -32.02 39.67 
r = correlation coefficient; bias = mean difference; variability represented by (5-precentile = [mean - (σ 
x 1.96)]; 95-precentile = [(σ x 1.96) +mean]); average value = the average of all the data point in x-axis 
from Band-Altman plot. 
All methods give a good correlation with correlation coefficients (r) ≥ 0.98 with an 
exception to SUVR where (r) = 0.95. The reason to include Bland-Altman plots was 
to see if the bias and variability are constant over the range of values that were used 
in the plots. 
 
Invasive arterial blood sampling methods (2T4k DVR and Logan DVR) gave biases > 
1.0, which were lower than the non-invasive reference region methods where the 
biases < 1.0. The SUVR was observed to give the bias of -35.2, which is higher than 
any other method stated in table 4.1. 
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Table 4.2: Relative bias (%) and variation (5-percentile and 95-percentile) (%) calculated by arterial 
blood sampling models (2T4k, Logan) and reference models (Loganref, RTM, SRTM, SUVR) for 
18
F-
fallypride in high uptake region (putamen) 
Arterial blood sampling models 
(invasive)  
Relative bias 5-percentile 95-percentile 
2T4k DV  
Logan DV  
2T4k DVR  
Logan DVR  
0.0% -2.0% 1.9% 
1.7% -0.9% 3.6% 
1.6% -0.6% 3.5% 
3.5% 2.8% 5.5% 
Reference region models 
 (non-invasive) 
Relative bias 5-percentile 95-percentile 
Logan REF DVR  
RTM DVR  
SRTM DVR  
SUVR 
7.3% 4.0% 9.8% 
4.9% 2.0% 6.9% 
4.8% 1.9% 7.0% 
-88.8% -98.1% -80.7% 
Relative bias (%) = [(bias/average value) x 100%]; variability represented by (5-precentile (%) = [5-
precentile/average value x100%; 95-precentile (%) = [95-precentile/average value x100%) 
Compared to the actual values of DVR, the relative bias and variation of 5th to 95th 
percentile ranges vary form one method to the other, with SUVR being the highest in 
(table 4.2). It was observed that the invasive arterial blood sampling methods gave 
relative biases lower than those observed using non-invasive reference region 
methods. The lowest relative bias was observed with 2T4k method. This was 
however not surprising because 2T4k method was regarded as the ground truth 
method.  
The criteria or benchmarks used to determine if the non-invasive reference region 
methods can be use as the replacement of the invasive arterial blood sampling 
methods were met. In non-invasive reference region methods, SRTM DVR was 
found to have the lowest relative bias of 4.8%. 
 
4.1.2   Brain regions with moderate (thalamus) and low (temporal cortex) receptor 
density  
The regression and Bland-Altman plots for the distribution volume (DV) for models 
which require blood sampling for 2T4k and Logan method are shown in figure 4.3. 
In the regression analysis plots (refer to figure 4.3), it was observed that most of the 
points fall on or close to the dotted line (line of identity). The true values of DV are 
therefore well estimated by applying these methods in low/moderate uptake regions.  
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Figure 4.3: Regression and Bland-Altman plots for the distribution volume (DV) obtained in 
low/moderate uptake regions by the 2T4k model (A(i) and A(ii)) and the Logan model (B(i) and B(ii)) 
compared to the ground-truth values.  
 
Both invasive arterial blood sampling methods (2T4k DV and Logan DV) have a 
constant bias with a good correlation (r = 0.99) when comparing their DV values with 
the true DV values. 
 
The constant bias is observed in both methods with the bias of 0.01 and -0.01 for 
2T4k and Logan respectively in figure 4.3 (A(ii) and B(ii)) on Bland-Altman plots. 
 
                 
A(i) A(ii) B(i) B(ii) 
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Figure 4.4: Regression and Bland-Altman plots for the distribution volume ratio (DVR) obtained in 
low/moderate uptake regions by the 2T4k model (A), Logan model (B), RTM (C), SRTM (D), Loganref 
(E) and SUVR (F) compared to the ground-truth values.  
 
Figure 4.4 shows the distribution volume ratio (DVR) obtained in low/moderate 
uptake regions. The results of the plots show the regression and Bland-Altman plots 
for invasive arterial blood sampling models and non-invasive reference region 
models. 
 
A good correlation coefficient (r) = 0.99 was observed for all invasive and non-
invasive methods in the regression plots. This good correlation showed that the DVR 
values estimated by different models were positively correlated with the true DVR 
values. 
  
 
     
 
A(i) A(ii) B(i) B(ii) 
C(i) 
C(ii) 
D(i) D(ii) 
E(i) E(ii) 
F(i) 
F(ii) 
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SUVR however, showed a correlation coefficient (r) = 0.90 in figure 4.4 F(i), with 
further analysis on Bland-Altman plot (figure 4.4 F(ii)) with bias of -0.33. The 
summary of the results is presented in table 4.3 
 Table 4.3: Comparison of arterial blood sampling models (2T4k and Logan) and reference models 
(Loganref, RTM, SRTM, SUVR) for the description of 
18
F-fallypride in low/moderate uptake region 
(temporal cortex and thalamus) 
Arterial blood sampling models 
(invasive) 
r bias 5-
percentile 
95-
percentile 
average value 
(unit less) 
2T4k DV  0.99 -0.01 -0.12 0.05 1.98 
Logan DV  0.99 0.01 -0.07 0.06 1.97 
2T4k DVR  0.99 -0.03 -0.15 0.03 2.06 
Logan DVR  0.99 0.01 -0.08 0.07 2.06 
Reference region models 
(non-invasive) 
r bias 5-
percentile 
95-
percentile 
average value 
(unit less) 
Logan REF DVR  0.99 0.01 -0.08 0.06 2.05 
RTM DVR  0.99 -0.01 -0.07 0.08 2.01 
SRTM DVR  0.99 0.00 -0.12 0.07 2.05 
SUVR 0.90 -0.33 -1.03 0.12 2.21 
r = correlation coefficient; bias = mean difference; variability represented by (5-precentile = [mean - (σ 
x 1.96)]; 95-precentile = [(σ x 1.96) +mean]); average value = the average of all the data point in x-axis 
from Band-Altman plot. 
In table 4.4, the relative bias and variation of 5th to 95th percentile ranges in 
low/moderate uptake regions are shown. 
Table 4.4: Relative bias (%) and variation (5-percentile and 95-percentile) (%) calculated by arterial 
blood sampling models (2T4k, Logan) and reference models (Loganref, RTM, SRTM, SUVR) for 
18
F-
fallypride in low/moderate uptake region (temporal cortex and thalamus) 
Arterial blood sampling models 
(invasive) 
Relative bias 5-percentile 95-percentile 
2T4k DV  -0.7 -6.1 2.5 
Logan DV  0.5 -3.6 3.0 
2T4k DVR  -1.5 -7.3 1.5 
Logan DVR  0.5 -3.9 3.4 
Reference region Models 
(non-invasive) 
Relative bias 5-percentile 95-percentile 
Logan REF DVR  0.2 -3.9 2.9 
RTM DVR  -0.3 -3.6 3.8 
SRTM DVR  0.2 -5.9 3.4 
SUVR -14.9 -46.6 5.6 
Relative bias (%) = [(bias/average value) x 100%]; variability represented by (5-precentile (%) = [5-
precentile/average value x100%; 95-precentile (%) = [95-precentile/average value x100%) 
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Compared to the actual values of DV, the bias is small with relative average biases of 
-0.7% and 0.5% for 2T4k and Logan respectively. Variation is also small with 5th to 
95th percentile ranges of -6.1% to 2.5% for 2T4k, and -3.6% to 3.0% for Logan in 
low/moderate uptake areas. 
 
The criteria used to determine if the non-invasive reference region methods can be 
use as the replacement of the invasive arterial blood sampling methods were met. 
For non-invasive reference region methods, Loganref DVR and SRTM DVR were both 
found to have the lowest relative bias of 0.2% followed by RTM DVR with the relative 
error of -0.3%. SUVR holds the highest relative error of -14.9%. 
 
SUVR calculations are probably not among the best methods for quantification 18F-
fallypride as they produce relatively large errors. For this specific reason, SUVR was 
completely excluded in this study for investigating models performance under varying 
conditions such as total scan duration, noise-level and breaks in sampling scheme 
for all brain regions. 
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4.2   The effect of noise-level variation/signal to noise ratio (SNR) in brain 
regions with high, moderate, and low receptor density 
4.2.1   Brain region with high receptor density (putamen) 
 
The relative error (in %) for DV and DVR is plotted against noise levels (f = 0.05, 0.1, 
0.15, 0.20, 0.25 and 0.30) for different VOIs (putamen, temporal cortex and 
thalamus) using different models. The ground truth values were used as a reference.  
 
 Figure 4.5: The plots of the relative error (%) against the noise level (SNR) for the distribution volume 
(DV) and the distribution volume ratio (DVR) in the brain region with high receptor density (putamen). 
The plots show invasive arterial blood sampling methods (2T4k and Logan) and reference region 
methods (RTM, SRTM and Loganref).  
 
From figure 4.5 the variability (5th and 95th percentiles) of all 5 methods increases 
with increasing noise as expected. The change in the relative error of 2T4k, RTM and 
SRTM keep the similar trend with the increasing noise with almost constant change 
in relative error as the noise level increases.  
The change in the relative error for Logan and Loganref also keep the similar the 
similar trend with the increasing noise, but the values turn towards negative values 
with increasing noise levels. 
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4.2.2   Brain region with moderate (thalamus) and low (temporal cortex) receptor 
density 
            
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: The plots of the relative error (%) against the noise level (SNR) for the distribution volume 
(DV) and the distribution volume ratio (DVR) in the brain region with moderate and low receptor 
density (thalamus (A) and temporal cortex (B)). The plots show invasive arterial blood sampling 
methods (2T4k and Logan) and reference region methods (RTM, SRTM and Loganref).  
 
 
 
 
B 
 
 
 
 
A 
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In figure 4.6 all the methods used in the brain regions with moderate (thalamus) and 
low (temporal cortex) receptor density perform similarly, with very little change in the 
relative error as the noise level increases. 
The variability (5th and 95th percentiles) of all 5 methods increases with increasing 
noise as expected. 
In all cases, the relative error and variability were found to be within the range of 
±10% at any given data point. This passes the set criteria which conclude that the 
non-invasive reference region methods can be use as the replacement of the 
invasive arterial blood sampling. 
4.3   The effect of total scan duration (continuous sampling scheme) in brain 
regions with high, moderate, and low receptor density  
4.3.1   Brain region with high receptor density (putamen)  
Figure 4.7 below shows the simulated graphs of the relative error plotted against 
scan duration (continuous sampling scheme) in the brain region with high receptor 
density (putamen) using invasive and non-invasive methods. 
 
Figure 4.7: The plots of the relative error (%) against the scan duration (continuous sampling scheme) 
for the distribution volume (DV) and the distribution volume ratio (DVR) in the brain region with high 
receptor density (putamen). The plots show invasive arterial blood sampling methods (2T4k and 
Logan) and reference region methods (RTM, SRTM and Loganref).  
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RTM, SRTM and both Logan methods (invasive and non-invasive) all tend to 
converge from a strongly negative bias for shorter scan duration, towards a less 
negative bias with increasing scan duration in high uptake areas (figure 4.7). The 
2T4k method shows an initially positive bias which decreases when scan duration 
increases.  
The variability decreases with increasing scanning time as expected for the 2T4k and 
Logan methods. This is only true up to 150 min. However, variability of the RTM, 
SRTM, and Loganref models is relatively insensitive to the scan duration. 
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4.3.2   Brain regions with moderate (thalamus) and low (temporal cortex) receptor 
density 
            
              
               
 
Figure 4.8: The plots of the relative error (%) against the scan duration (continuous sampling scheme) 
for the distribution volume (DV) and the distribution volume ratio (DVR) in the brain region with 
moderate (A) and low (B) receptor density. The plots sh 
ow invasive arterial blood sampling methods (2T4k and Logan) and reference region methods (RTM, 
SRTM and Loganref).  
 
 
 
 
A 
 
 
 
 
B 
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From figure 4.8, all methods show almost no bias with the increasing scan duration. 
This is true for scan duration ≥ 120min. 
In all cases, the relative error and variability were found to be within the range of 
±10% for scan duration ≥ 120min. The non-invasive reference region methods can be 
use as the replacement of the invasive arterial blood sampling for scan duration ≥ 
120min. 
4.4   The effect of scan duration with breaks (interrupted sampling scheme) in 
brain regions with high, moderate, and low receptor density  
4.3.3   Brain region with high receptor density (putamen)  
 
The different interrupted sampling schemes are shown in table 3.2 and 3.3. 
 
Figure 4.9: The plots of the relative error (%) against the scan duration with breaks (interrupted 
sampling scheme) for the distribution volume (DV) and the distribution volume ratio (DVR) in the brain 
region with high receptor density (putamen). The plots show invasive arterial blood sampling methods 
(2T4k and Logan) and reference region methods (RTM, SRTM and Loganref). 
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The change in the relative error and variability of the RTM, SRTM, Logan and 
Loganref methods keeps similar trend in shape throughout different sampling 
schemes. 
The interrupted sampling schemes (1-5) with breaks of 1 hour have a smaller relative 
error than interrupted sampling schemes (6 - 8) with breaks of 2 hours including the 
interrupted sampling scheme (10) with the break of 3 hours.  
The interrupted sampling scheme (9) with the break of 3 hours has a larger bias than 
any other sampling scheme chosen for this study. In simple terms, the bias increases 
as the interrupted breaks between scans are prolonged. 
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4.3.4   Brain regions with moderate (thalamus) and low (temporal cortex) receptor 
density 
            
 
Figure 4.10: The plots of the relative error (%) against the scan duration with breaks (interrupted 
sampling scheme) for the distribution volume (DV) and the distribution volume ratio (DVR) in the brain 
region with moderate (A) and low (B) receptor density. The plots show invasive arterial blood sampling 
methods (2T4k and Logan) and reference region methods (RTM, SRTM and Loganref).  
The change in the relative error and variability of the RTM, SRTM, Logan and 
Loganref methods keeps similar trend in shape throughout different sampling 
schemes. 
 
 
 
 
B 
 
 
 
 
A
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In figure 4.10 (A), moderate receptor density (thalamus), the change in the relative 
error and variability of the RTM, SRTM, Logan and Loganref methods, keeps similar 
trend in shape throughout different sampling schemes. The same trend is also 
observed in low receptor density (temporal cortex), figure 4.10 (B). 
All sampling schemes with interrupted breaks of 1 hour (sampling scheme 1-5), 2 
hours (sampling scheme 6-8), and 2.5 hours (sampling scheme 10) have a small bias 
for RTM and SRTM except for 3 hours interrupted breaks (sampling scheme 9), 
which has a larger bias than any other acquisition chosen for this study. In simple 
terms, the bias increases as soon as the interrupted breaks between scans reach 3 
hours. 
The bias is also small for all sampling schemes with interrupted breaks of 1 hour 
(acquisition scheme 1-5), 2 hours (acquisition scheme 6-8), and 2.5 hours 
(acquisition scheme 10) for Logan and Loganref in both figure 4.10 (A) and (B). 
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Chapter 5: Discussion 
This study explored the quantification of a simplified measurement protocol that 
omitted invasive arterial blood sampling. We studied the following graphical and/or 
simplified models: (1) LGA , (2) Loganref, (3) RTM, (4) SRTM (5) SUVR measured as 
the ratio of the activity in a region of interest, the activity in the cerebellum and (6) 
2T4k as the ground truth model to analyze 18F-fallypride PET for visualization of 
D2/D3 receptors in the brain. 
The three research questions (primary objectives) formulated in this study are 
discussed. For each of them, we first discuss the use of a graphical method (the 
Logan model), followed by the discussion of reference region models which do not 
require arterial blood sampling and finally the use of SUVR as a very simple method. 
In the discussions we have elaborated on applicability for high/moderate/low receptor 
density regions and formulated a conclusion based on the data we have presented 
per research topic.  
The models were assessed in terms of their relative biases, variation, reproducibility 
and their reliability. 
 
5.1   The accuracy/reliability of various methods in18F-fallypride quantification 
5.1.1   LGA 
It was found that for 18F-fallypride, the DV and DVR for 2T4k and LGA gave high 
correlation and the results showed striking resemblance between the two methods. 
The results also showed relatively small inter-variation when two methods were 
compared to each other due to their small relative average biases and variability in 
both high and low receptor density regions. 
LGA showed a slight underestimation of DV compared to 2T4k which is correlation to 
the study performed by Carson et al., (1993) and Slifstein and Laruelle et al., (2000)  
In their study (Siessmeier et al., 2005), found that the 18F-fallypride estimates of DVR 
for the graphical methods were usually lower than estimates of DVR obtained with 
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the compartmental model in receptor-rich regions, which is in agreement with our 
study. 
2T4k is theoretically the best model. If simplified models were to be used (e.g. Logan 
model) with blood sampling, it shows that Logan is still useful in a sense that it works 
almost equally well as the 2T4k model. Then parametric modeling on a voxel base 
for the estimation of DV, DVR can be used because it is quick (Logan et al., 2011; 
Logan (2003).  
5.1.2   Loganref 
It was found that the relative average bias and variation obtained Loganref were large 
in the regions of high receptor density compared to the regions of low/moderate 
receptor density but within the limits of set criteria in both cases. 
This means Loganref can be used as a simplified measurement protocol that omitted 
arterial blood sampling in all regions but it is highly favoured in the regions of 
low/moderate receptor density. 
5.1.3   RTM 
RTM DVR showed larger relative bias of 4.9% in high receptor density region and 
smaller relative bias of -0.3% in low/moderate receptor density regions. 
This method passed the set criteria and can be used as the replacement of the 
invasive arterial blood sampling methods in all the receptor density regions. 
5.1.4   SRTM 
The smallest relative average bias and variation were observed with the results in 
close proximity to the 2T4k method in low/moderate than in high receptor density 
region. It is clear that when the relative average biases are small, the estimation of 
DVR is well achieved. This method can be used to replace the invasive arterial blood 
sampling methods in all receptor density regions. 
5.1.5   SUVR 
The relative biases were larger with more variability in SUVR results in all receptor 
density regions, thus causing the results to produce a proportional bias. With SUVR, 
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much less true quantification is captured and the error produced also depends on the 
obtained values. This makes things tricky because the bias is not constant.  
These findings reveal that using SUVR as a quantification for 18F-fallypride is not 
ideal. Our results suggest that SUVR calculations are probably not among the best 
ones, because they produce relatively large errors. We do not recommend it as the 
method of choice as a replacement for the invasive arterial blood sampling methods. 
 
5.2   The effect of noise-level variation/signal to noise ratio (SNR) in brain 
regions with high, moderate, and low receptor density 
5.2.1   LGA 
Our study shows that in high, low/moderate receptor density region, the variability of 
Logan graphical analysis increases with increasing noise as expected.  
At these higher noise levels, a corresponding bias becomes apparent and LGA tends 
towards negative bias with increasing noise in high receptor density region. This is in 
agreement with the paper documented by Slifstein and Laruelle et al., (2000), which 
states that the higher noise levels have been shown to introduce a negative bias 
estimated by the Logan graphical analysis.  
The relative error and variability were well within tolerance in all receptor density 
regions based on the set criteria. 
 5.2.2   Loganref 
The results here are almost similar to the LGA described in section 5.2.1 above. 
The relative error and variability were well with in tolerance based on the set criteria 
in all receptor density regions. Loganref can be used as the replacement of the 
invasive arterial blood sampling methods in all the receptor density regions. 
 
5.2.3   RTM 
The relative error and variability were well with in tolerance based on the set criteria 
in all receptor density regions. RTM can be used as the replacement of the invasive 
arterial blood sampling methods in all the receptor density regions. 
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5.2.4   SRTM 
 
Increasing noise increases the variability of SRTM.  A conclusion can be made that 
SRTM can be used as the replacement of the invasive arterial blood sampling 
methods in all the receptor density regions since it produces a small relative error.  
 
5.3   The effect of total scan duration (continuous sampling scheme) in brain 
regions with high, moderate, and low receptor density. 
 
For continuous scanning, kinetic modeling estimates for 18F-fallypride with LGA, 
Loganref, RTM and SRTM were found to be reasonably stable with less relative errors 
in DVR, but required long scan durations (> 150 min) in high receptor density regions 
and scan durations of > 120 min in low/moderate receptor density regions. 
 
In their studies, Constantinescu et al., (2011) and Honer et al., (2004), used the 
maximum scan duration of up to 150 min for 18F-fallypride studies. It was found that 
at 150 min the kinetics of 18F-fallypride were stable.  
Ishibashi et al., (2013) stated that 18F-fallypride has relatively slow kinetics, thus 
requiring a prolonged scanning time, at least 120 to 180 min scan duration. Similarly, 
Tantawy et al., (2009) used a total scan duration of 120 min. 
 
5.4   The effect of the scan duration with breaks (interrupted sampling scheme) in 
brain regions with high, moderate, and low receptor density.  
The acquisitions schemes are divided into the following groups (refer to table 3.2 and 
table 3.3): 
The scan duration with 1 hour break are (interrupted sampling scheme 1-5), 2 hour 
break are (interrupted sampling scheme 6-9), 3 hour break is (interrupted sampling 
scheme 9) and 2.5 hour break is (interrupted sampling scheme 10) 
 
The change in the relative error and variability of the RTM, SRTM, Logan and 
Loganref methods keeps similar trend in shape throughout different sampling 
schemes in high receptor density region. The same trend is also observed in 
moderate and low receptor density regions. 
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The interrupted sampling schemes (1-5) with breaks of 1 hour have a smaller relative 
error than interrupted sampling schemes (6 - 8) with breaks of 2 hours including the 
interrupted sampling scheme (10) with the break of 3 hours.  
The interrupted sampling scheme (9) with the break of 3 hours has a larger bias than 
any other sampling scheme chosen for this study. This might be due to a short scan 
at the beginning, followed by a long break. In simple terms, the bias increases as the 
interrupted breaks between scans are prolonged. 
 
The most important factor in using interrupted sampling schemes is a clear 
understanding of the research population. What might seem reasonable in terms of 
interrupted sampling schemes with breaks for one patient group (older patients) 
might be totally inappropriate for another group (e.g. paediatric patients). Hence the 
recommendation on the interrupted sampling schemes with the break is required. 
 
Our results suggest that when a scanning break is introduced, best quantitative 
results are achieved if a 30 min break is commenced immediately after 30 minutes of 
scanning. 
This should be followed by the second break (120 min long) after 90 min of scanning 
(i.e. 30 min scan + 30 min break + 30 min scan). 
The total duration of the scan was 90 min and the total length of the break was 150 
min. 
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Chapter 6: Conclusions and future research 
The following conclusions can be drawn from the findings of this study. 
When addressing the accuracy and reliability of various methods in18F-fallypride 
quantification, parameter estimation is important. The LGA model allows parametric 
modelling on a voxel base for the estimation of DV, DVR and works almost as well as 
the 2T4k model.  
All the various non-invasive reference region methods (Loganref, RTM and SRTM) 
were accurate and reliable in quantification of 18F-fallypride. They can all be used as 
the replacement of the invasive arterial blood sampling. 
The Loganref method was the most accurate, with the highest precision as the 
replacement of the invasive arterial blood sampling in low/moderate receptor density 
regions. While SRTM gave high precision in high receptor density region, SUVR 
calculations produce relatively large errors in all brain receptor density regions used 
in this study. 
 
The effect of noise shows the relative error and variability increase with the 
increasing noise level variation in high, moderate and low receptor density regions. 
LGA, Loganref, RTM and SRTM produced results comparable to 2T4k method, 
therefore, all the non-invasive reference region methods used in this study are 
recommended to be used as the replacement of the invasive arterial blood sampling 
methods. 
 
Addressing the issues of the scan duration, LGA, Loganref, RTM and SRTM can be 
used as the replacement of the invasive arterial blood sampling methods if the scan 
length (continuous sampling scheme) > 150 min in high receptor density region and > 
120 min in low/moderate receptor density regions. 
 
Addressing the issue of interrupted sampling scheme with breaks depends on the 
patient population group. The interrupted sampling schemes with breaks for one 
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patient group (older patients) might be totally inappropriate for another group (e.g. 
paediatric patients). 
Our results suggest that when a scanning break is introduced, best quantitative 
results are achieved if a 30 minute break is commenced immediately after 30 
minutes of scanning. This should be followed by a second break (120 minutes long) 
after 90 minutes of scanning (i.e. 30 minutes scan + 30 minutes break + 30 minutes 
scan). 
In total, the duration of the two breaks together should not be longer than 150 
minutes. 
 
Future clinical and research applications  
Since the tracer behaviour can be approximated by the ground truth model, the 
second line of research evolves around the idea of using a much more complex and 
accurate ground truth model, because the current study uses the 2T4k model of 18F-
fallypride as the ground truth model for simulations. In reality the ground truth model 
is much more complex in a sense that the complexity is based on the parameters 
involving physiological and biological pathways of the tracer’s molecule in the brain. 
The complexity of the ground truth model will be improved to properly describe the 
complex dynamic processes and the behaviour of 18F-fallypride in the brain. 
However, the model will be reconstructed in such a way that it not too complicated to 
be used to analyze PET studies. This means fine tuning simulations to look at 
ideological aspects of 18F-fallypride, and how this tracer is behaving and what the 
dopamine receptors are doing in the brain. 
Moreover, it would be interesting for future research to consider studying both the 
time-varying fluctuating levels of the dopamine concentration and its competition with 
the radiotracer for the available D2/D3 binding sites by exploring the activation 
studies. 
Once 18F-fallypride becomes clinically available on the South African market, it would 
be an exciting project to compare actual clinical data with these and other kinetic 
models.  
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Appendix 
 
A. Modelling the fraction of the intact tracer 
 
function [intact_fractions] = LCN_calc_intact_tracer_hill(params,times) 
% 
% the function y(t) = b/(1+(a/t)^n) will be fitted with b set to 1 
% b = asymptotic value, assumed 1 at time 0 (100% intact tracer) 
% a = t where the function reaches half of its maximum (b/2) 
% n determines the steepness of the slope 
% 
% FORMAT: intact_fractions = LCN_calc_intact_tracer_hill(params,times) 
% 
% params: [a, n] 
% times: array of times in minutes 
% intact_fractions: intact fraction of tracer (between 0 and 1) 
%__________________________________________________________________________ 
% 
% author: Natalie Nelissen, Patrick Dupont 
%__________________________________________________________________________ 
% @(#)LCN_calc_intact_tracer_hill.m      1.0      
  
intact_fractions = 1./(1+(params(1)./times).^params(2)); 
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B. Simulation/modelling of a representative input function 
 
function [Ca] = LCNSIM_input_function(t,ts,tp,A,beta) 
% this function calculates a theoretical input function defined by 
% parameters ts, tp, A and beta at time points t (array of times in min). 
% Ca = 0 if t < ts 
% Ca = (t-ts).*(A1+A2+A3)/(tp-ts) 
% Ca = A(1)*exp(-log(2)*(t-tp)/beta(1)) + A(2)*exp(-log(2)*(t-tp)/beta(2)) 
+ A(3)*exp(-log(2)*(t-tp)/beta(3))  
% output = array of concentrations (kBq/ml) of the theoretical input 
% function 
  
index1 = (t<=ts); 
index2 = (t<=tp); 
index3 = (t>tp); 
  
Ca(index3) = A(1)*exp(-log(2)*(t(index3)-tp)/beta(1))+A(2)*exp(-
log(2)*(t(index3)-tp)/beta(2))+A(3)*exp(-log(2)*(t(index3)-tp)/beta(3)); 
Ca(index2) = (t(index2)-ts).*sum(A)/(tp-ts); 
Ca(index1) = 0; 
 end 
%++++++++++++++++ SETTINGS+++++++++++++++++++++++++++++++++++++++++++++++++ 
 %% ideal input function 
ts   = 0.35; % min 
tp   = 0.7; % min 
A    = [743.2432432432 202.7027027027 25.0]; % KBq/ml 
beta = [0.1 1.2 100]; % min 
MAX_TIME_INPUT = 200; % min 
  
%% model for the intact fraction  
param_hill = [70 -0.6];  
STEP = 0.001; % step size for the calculation of integrals in min 
  
FINETIMES = [0:STEP:MAX_TIME_INPUT]'; % min 
% determine the input function 
[Ca] = LCNSIM_input_function(FINETIMES',ts,tp,A,beta)'; % uncorrected input 
  
% determine the model for intact fraction of tracer 
intact_hill = LCN_calc_intact_tracer_hill(param_hill,FINETIMES); 
  
% correct the input function for the intact fraction 
Ca_corr = Ca.*intact_hill; % corrected input function  
CA_FINETIMES = Ca_corr; 
  
subplot(1,3,1) 
   plot(FINETIMES,Ca) 
   xlabel('Time (min)') 
   ylabel('Arterial activity concentration, nCi/cc') 
   title('Input function') 
   subplot(1,3,2) 
  plot(FINETIMES,intact_hill) 
  xlabel('Time (min)') 
   ylabel('Percent of 18F-fallypride(simulated intact fraction)') 
   title('Fraction of the intact tracer') 
   hold on 
  
   subplot(1,3,3) 
   plot(FINETIMES,Ca_corr) 
   xlabel('Time (min)') 
   ylabel('Arterial activity concentration, nCi/cc') 
   title('Decay corrected input function') 
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C. Analysis using different methods 
% analysis using 2T4k 
%-------------------------------------------------------------------------- 
ESTIMATED_K_PARAMS = tmp1_Kvalues(:,index_tmp_error(1)); 
DV_2T4k(i_voi,k)= 
(ESTIMATED_K_PARAMS(1)./ESTIMATED_K_PARAMS(2)).*(1+ESTIMATED_K_PARAMS(3)./E
STIMATED_K_PARAMS(4)); 
 
% calculate SUVR 
%-------------------------------------------------------------------------- 
SUVR(i_voi,j,k) = mean(C_MEASURED(end-4:end))./SUV_REF(j);  
 
% analysis using Logan 
%-------------------------------------------- 
[VD,error] = 
LCN_LOGAN(MIDSCANTIMES,C_MEASURED,FINETIMES,CA_FINETIMES,logan_start_time,0
); 
DV_Logan(i_voi,j,k) = VD; 
                    
% analysis using Logan_ref 
%-------------------------------------------------------------------------- 
[slope,error] = 
LCN_LOGAN_ref(MIDSCANTIMES,C_MEASURED,C_REF,logan_start_time,0); 
DVR_Logan_ref(i_voi,j,k) = slope; 
 
% analysis using RTM 
%-------------------------------------------------------------------------- 
ESTIMATED_K_PARAMS = tmp1_Kvalues(:,index_tmp_error(1)); 
DVR_RTM(i_voi,j,k)   = ESTIMATED_K_PARAMS(4)+1; 
 
 
% analysis using SRTM 
%-------------------------------------------------------------------------- 
DVR_SRTM(i_voi,j,k)   = ESTIMATED_K_PARAMS(3)+1; 
 
% True DV values  
%-------------------------------------------------------------------------- 
DV_TRUE  =  
(params_gold_standard(:,1)./params_gold_standard(:,2)).*(1+params_gold_stan
dard(:,3)./params_gold_standard(:,4)); 
 
% True DV values in reference region  
%-------------------------------------------------------------------------- 
DV_TRUE_REF  =  
(params_gold_standard_ref(:,1)./params_gold_standard_ref(:,2)).*(1+params_g
old_standard_ref(:,3)./params_gold_standard_ref(:,4)); 
DVR_TRUE = DV_TRUE./DV_TRUE_REF; 
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D. The Correlation and Bland-Altman plots for 2T4k method 
% generate plots 
% plot correlations with true values as well as bland-altman plots for each 
% method 
  
% 2T4k 
%-------------------------------------------------------------------------- 
figure 
subplot(1,2,1) 
x = DV_TRUE; 
y = DV_2T4k; 
[R, p] =corrcoef(x,y); 
r = R(1,2);         
dif = x-y; 
average = (x+y)./2;     
plot(x,y,'*') 
xlabel('DV (true)') 
ylabel('DV (2T4k)') 
hold on 
plot([0.9*min(x) 1.1*max(x)],[0.9*min(x) 1.1*max(x)],':') 
P = polyfit(x,y,1); 
xvalues = [0.9*min(x) 1.1*max(x)]; 
plot(xvalues,P(1).*xvalues+P(2),'-r') 
title(['r = ' num2str(r)]) 
     
subplot(1,2,2) 
plot(average,dif,'*') 
xlabel('average DV') 
ylabel('DV (true) - DV (2T4k)') 
hold on 
plot([0 1.1*max(average)],[mean(dif) mean(dif)]) 
% determine 5 and 95 percentiles 
aa = sort(dif); 
threshold_5p = aa(round(length(aa)*0.05)); 
threshold_95p = aa(round(length(aa)*0.95)); 
plot([0 1.1*max(average)],[threshold_5p  threshold_5p],':') 
plot([0 1.1*max(average)],[threshold_95p  threshold_95p],':') 
title(['bias = ' num2str(mean(dif))]) 
if min(aa) < 0 
   lower_value = min(1.1*min(aa),-0.2*min(average)); 
else 
   lower_value = min(0.9*min(aa),-0.2*min(average)); 
end 
if max(aa) < 0 
   upper_value = max(0.2*max(average)); 
else 
   upper_value = max(1.1*max(aa),0.2*max(average)); 
end 
axis([0.9*min(average) 1.1*max(average) lower_value upper_value])  
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E. The relative error (%) and SNR/Scan duration for 2T4k method 
 
%plot error = relative difference between calculated DV and DV_TRUE per VOI 
%-------------------------------------------------------------------------- 
xvalues   = noise_levels(1:end); 
nr_values = length(xvalues); 
for i_voi = 1:nr_VOIS 
    clear error tmp stdvalues meanvalues 
    figure 
     
% 2T4k 
%-------------------------------------------------------------------------- 
    subplot(2,4,1) 
    tmp = squeeze(DV_2T4k(i_voi,:,:)); 
    error = 100*(tmp-DV_TRUE(i_voi))./DV_TRUE(i_voi); 
    meanvalues = zeros(nr_values,1); 
    if nr_noise_realizations > 1 
       for j = 1:nr_values 
           clear datavalues 
           datavalues = error(j,:); 
           % remove NaN or Inf 
           index_ok1 = (~isnan(datavalues)).*(~isinf(datavalues)); 
           datavalues = datavalues(index_ok1 > 0); 
           % identify outliers 
           [outlier_index] = 
LCN_detect_outliers_univariate_data(datavalues,'classical');  
           index_ok2 = setdiff([1:length(datavalues)]',outlier_index); 
           meanvalues(j) = mean(datavalues(index_ok2)); 
           stdvalues(j)  = std(datavalues(index_ok2)); 
           minvalues(j)  = min(datavalues(index_ok2)); 
           maxvalues(j)  = max(datavalues(index_ok2)); 
       end 
       plot(xvalues,meanvalues,'*') 
       plot(xvalues,stdvalues,'*') 
        
       hold on 
        errorbar(xvalues,meanvalues,stdvalues,stdvalues) 
       plot(xvalues,maxvalues,':') 
       plot(xvalues,minvalues,':') 
              hold on 
  
    else 
       plot(xvalues,error,'o') 
       hold on 
    end     
    plot([0 xvalues(end)],[0 0])         
    xlabel('SNR (min)') 
    ylabel('relative error DV (%)') 
    axis([0 xvalues(end) -20 20]) 
    title('DV 2T4k') 
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